,Expression,PathwayName,Number of Genes
1642,2.8695140080045003,Metal sequestration by antimicrobial proteins,6
2201,1.9115476972796894,"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)",1
485,1.8631478053062112,CD22 mediated BCR regulation,61
1395,1.7748473167307104,Type I hemidesmosome assembly,11
475,1.7682194686067638,Classical antibody-mediated complement activation,63
182,1.728351956269481,FCGR activation,132
186,1.6721946666841465,Formation of the cornified envelope,130
426,1.6379667294120286,Scavenging of heme from plasma,69
2159,1.60942231682284,Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B,1
173,1.6040823381582137,Role of LAT2/NTAL/LAB on calcium mobilization,136
421,1.6028904708126,Creation of C4 and C2 activators,71
2176,1.553778986277215,t(4;14) translocations of FGFR3,1
136,1.5357836846502964,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,163
373,1.5067758472818795,Initial triggering of complement,79
1765,1.5036971513729285,Melanin biosynthesis,5
355,1.4422501877251064,Role of phospholipids in phagocytosis,83
139,1.4390696900266173,FCERI mediated Ca+2 mobilization,162
1375,1.4052156370420104,Apoptotic cleavage of cell adhesion  proteins,11
2231,1.3986395639206641,Defective CYP1B1 causes Glaucoma,1
2070,1.3796078561348912,Variant SLC6A14 may confer susceptibility towards obesity,1
255,1.302661459070971,Regulation of Complement cascade,103
319,1.2980845645887618,FCERI mediated MAPK activation,90
2012,1.22465087740574,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),2
2001,1.22465087740574,Defective CP causes aceruloplasminemia (ACERULOP),2
220,1.209419557277375,Complement cascade,114
224,1.1867132547347956,Binding and Uptake of Ligands by Scavenger Receptors,111
78,1.0901462828983925,Fcgamma receptor (FCGR) dependent phagocytosis,239
71,1.0520178195024694,Signaling by the B Cell Receptor (BCR),259
92,1.0186542242060395,Keratinization,217
2150,1.0141642223314615,Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),1
110,1.0098072245267857,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,186
1891,1.0071308100407297,Transport of connexins along the secretory pathway,3
2164,0.9655650938342581,Defective ABCC2 causes Dubin-Johnson syndrome,1
67,0.9479915736808422,Fc epsilon receptor (FCERI) signaling,271
1624,0.9427247329641537,Interleukin-36 pathway,7
2066,0.9324049714910407,Methylation of MeSeH for excretion,1
149,0.9201097056603021,Regulation of actin dynamics for phagocytic cup formation,150
1833,0.91729807393536,Binding and entry of HIV virion,4
2136,0.916572039668523,Defective SLC1A3 causes episodic ataxia 6 (EA6),1
1734,0.9004832532473891,MET interacts with TNS proteins,5
1599,0.8918231243842002,Synthesis of 12-eicosatetraenoic acid derivatives,7
104,0.873208245476141,Cell surface interactions at the vascular wall,196
165,0.8669634403546365,FCERI mediated NF-kB activation,140
1994,0.8139569510439804,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),2
2098,0.8132725052471096,Defective SLC9A9 causes autism 16 (AUTS16),1
1901,0.8102192590710674,Rhesus glycoproteins mediate ammonium transport.,3
1832,0.8021962933758218,Oligomerization of connexins into connexons,4
2180,0.7989466532908924,Biosynthesis of DPAn-3-derived 13-series resolvins,1
1482,0.7969023143711057,Hydrolysis of LPC,9
2205,0.7929037229259854,Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA),1
1386,0.7816141887433303,EGFR Transactivation by Gastrin,11
2195,0.7604940000690775,Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD),1
1544,0.7589902559173959,Terminal pathway of complement,8
996,0.7522486791467214,Translocation of ZAP-70 to Immunological synapse,21
1889,0.7484221525920804,PTK6 Down-Regulation,3
2220,0.7433519476989324,Signaling by FGFR2 amplification mutants,1
2219,0.7433519476989324,Signaling by FGFR2 fusions,1
1071,0.7354169218483569,Regulation of TLR by endogenous ligand,19
1894,0.7080946533472591,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",3
926,0.7038402729060165,Phosphorylation of CD3 and TCR zeta chains,24
909,0.7014849014073057,PD-1 signaling,25
2181,0.6922470949909901,Tandem pore domain halothane-inhibited K+ channel (THIK),1
1142,0.6889445239813131,Acyl chain remodelling of PI,17
1851,0.6833821885525412,Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),3
1935,0.6795412648928824,ABO blood group biosynthesis,2
1808,0.6784839914660932,Neurophilin interactions with VEGF and VEGFR,4
1533,0.6741491984533232,RUNX3 Regulates Immune Response and Cell Migration,8
1453,0.6721073167737116,FGFR2b ligand binding and activation,10
1573,0.6633006104182453,Nef and signal transduction,8
1595,0.6410852604464188,Activation of C3 and C5,7
701,0.635300601053604,Apoptotic cleavage of cellular proteins,38
1699,0.633820947197574,PTK6 Expression,5
712,0.6325664719591348,Generation of second messenger molecules,37
1084,0.6289589152028219,Acyl chain remodelling of PG,18
2118,0.6187592828223193,Defective SLC26A4 causes Pendred syndrome (PDS),1
1729,0.6167637527840659,Alternative complement activation,5
987,0.6132590339059182,Acyl chain remodelling of PS,22
1645,0.6108249679154992,PTK6 promotes HIF1A stabilization,6
2092,0.6093068262824778,Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS),1
1904,0.6076835371505782,Regulation of thyroid hormone activity,3
1553,0.607392006266609,Cross-presentation of particulate exogenous antigens (phagosomes),8
1944,0.6001826506349593,Defective SLC7A7 causes lysinuric protein intolerance (LPI),2
1946,0.5997866033114034,Biosynthesis of DPAn-3-derived maresins,2
927,0.5996407350472961,RHO GTPases Activate NADPH Oxidases,24
1559,0.5994456309433971,Formyl peptide receptors bind formyl peptides and many other ligands,8
1687,0.5983835932156207,N-glycan trimming and elongation in the cis-Golgi,5
1447,0.5958463173995122,MyD88 deficiency (TLR2/4),10
1768,0.5929932719623201,Astrocytic Glutamate-Glutamine Uptake And Metabolism,4
1829,0.5929932719623201,Neurotransmitter uptake and metabolism In glial cells,4
596,0.5928293166439603,Chemokine receptors bind chemokines,48
1831,0.5924559019481314,Proton/oligopeptide cotransporters,4
1623,0.5913795467923062,Nectin/Necl  trans heterodimerization,7
1746,0.588607285162641,Leukotriene receptors,5
1662,0.568723942989294,RUNX1 regulates transcription of genes involved in BCR signaling,6
1312,0.5652036566417868,Regulation of localization of FOXO transcription factors,12
1602,0.5641940477078341,Activation of RAS in B cells,7
1335,0.5630635111208783,PECAM1 interactions,12
1512,0.5607554096688614,CHL1 interactions,9
2177,0.5599547548590593,TLR3 deficiency - HSE,1
1845,0.5589416269658912,Toxicity of botulinum toxin type E (BoNT/E),3
1369,0.555226696706354,IRAK4 deficiency (TLR2/4),11
2039,0.5511324723957922,Sterols are 12-hydroxylated by CYP8B1,2
870,0.5503496289930975,Acyl chain remodelling of PC,27
850,0.5502628132066014,TNFs bind their physiological receptors,28
829,0.5479995401254242,Acyl chain remodelling of PE,29
1854,0.5407347199660734,Hydroxycarboxylic acid-binding receptors,3
1043,0.5406914987270773,Gastrin-CREB signalling pathway via PKC and MAPK,20
1696,0.5363030767461449,PTK6 Regulates Proteins Involved in RNA Processing,5
1932,0.5358988590750493,Defective Mismatch Repair Associated With MSH6,2
1412,0.5349409024652703,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),10
1450,0.5344424546372724,Interleukin-21 signaling,10
1338,0.5343948195998626,CD28 dependent Vav1 pathway,12
1057,0.5327309848184164,Advanced glycosylation endproduct receptor signaling,19
1821,0.5324057473393925,Interleukin-38 signaling,4
14,0.5290942526313074,Adaptive Immune System,977
288,0.5271441622115852,Antimicrobial peptides,97
1211,0.5248274669752296,Interleukin-2 signaling,14
778,0.5239851722589078,Activation of Matrix Metalloproteinases,33
1803,0.5220331881435192,Intestinal hexose absorption,4
1011,0.5212744341669533,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,21
1425,0.5189965413324978,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,10
1415,0.5187663032392629,Signaling by FGFR3 fusions in cancer,10
1106,0.5180578089225343,Regulation of KIT signaling,18
1683,0.5177821799669989,MET Receptor Activation,6
2046,0.5167809241773232,APC truncation mutants are not K63 polyubiquitinated,1
558,0.5167771887335953,Apoptotic execution phase,53
623,0.5162689064758598,Interleukin-10 signaling,45
334,0.5138107204567448,Collagen degradation,89
1341,0.5116598154864359,P2Y receptors,12
10,0.5115599033047677,Innate Immune System,1277
1686,0.5113848910953309,RUNX1 regulates transcription of genes involved in interleukin signaling,5
1976,0.5088861023617923,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,2
1239,0.505647925898492,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,14
1108,0.5045942245411195,Signal regulatory protein family interactions,18
1864,0.5035807106526543,The IPAF inflammasome,3
2167,0.50340719269881,Defective ABCD1 causes adrenoleukodystrophy (ALD),1
1663,0.5023189900940922,MET activates PI3K/AKT signaling,6
1786,0.5013469762815695,ATP sensitive Potassium channels,4
1887,0.5010789689138873,Intracellular metabolism of fatty acids regulates insulin secretion,3
2121,0.4990002889767695,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),1
2133,0.4981646526402908,Defective SLC26A2 causes chondrodysplasias,1
1306,0.4978554426102251,Trafficking and processing of endosomal TLR,13
1523,0.49063023274624484,VEGF ligand-receptor interactions,8
1522,0.49063023274624484,VEGF binds to VEGFR leading to receptor dimerization,8
1947,0.4887788476060116,Biosynthesis of DPAn-3-derived protectins and resolvins,2
1418,0.48749621001145105,Cohesin Loading onto Chromatin,10
1353,0.48699155789697124,Eicosanoids,12
963,0.48691832331021556,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),23
2212,0.48665574831415165,Reactions specific to the hybrid N-glycan synthesis pathway,1
301,0.4861025817262719,Cell junction organization,95
1837,0.48503964523460885,The AIM2 inflammasome,4
1191,0.48405560197852426,Anchoring fibril formation,15
1920,0.4810039330348819,Interleukin-33 signaling,3
973,0.4802762003861305,Interleukin-15 signaling,22
1955,0.47793911942859924,Defective Mismatch Repair Associated With MSH3,2
2140,0.4775917028006761,"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",1
1915,0.47745548456713865,Defective Mismatch Repair Associated With MSH2,3
1732,0.4766238746831516,MET activates PTPN11,5
400,0.476196190383289,Costimulation by the CD28 family,73
2186,0.4743620786960685,Synthesis of IPs in the ER lumen,1
513,0.4741316138320223,Gap junction assembly,58
1210,0.4734676232536711,Nucleotide-like (purinergic) receptors,15
1727,0.47317570966069444,PTK6 Activates STAT3,5
108,0.47166089653396587,Degradation of the extracellular matrix,188
1408,0.4686828673063068,Establishment of Sister Chromatid Cohesion,11
536,0.4672096190856014,Laminin interactions,55
2032,0.46452570072002675,Nef mediated downregulation of CD28 cell surface expression,2
1403,0.4637161820500287,Creatine metabolism,11
2028,0.46208364372297855,"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia",2
807,0.46132351155622303,Dectin-2 family,31
1772,0.4613225009882472,Carnitine synthesis,4
584,0.4603151344178731,Signaling by SCF-KIT,50
1704,0.4594164008795268,Extrinsic Pathway of Fibrin Clot Formation,5
1717,0.45738344559362265,Disinhibition of SNARE formation,5
1752,0.45734504377937923,Hyaluronan biosynthesis and export,5
2119,0.4569342383918723,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),1
2016,0.45641228895511077,Biosynthesis of electrophilic Ï‰-3 PUFA oxo-derivatives,2
545,0.4558183129785505,Interleukin-2 family signaling,55
1941,0.4551346199741671,vRNP Assembly,2
1650,0.4549428999794247,PTK6 Regulates Cell Cycle,6
1858,0.454665907279463,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,3
482,0.45309294259162625,Assembly of collagen fibrils and other multimeric structures,61
1326,0.4529709148244328,Interleukin-35 Signalling,12
1825,0.45294113670526875,IRAK4 deficiency (TLR5),4
21,0.4509166756573569,Hemostasis,735
2096,0.45047332102370996,Defective GFPT1 causes CMSTA1,1
1798,0.45042773759627963,MET activates STAT3,4
1572,0.4501343652485148,Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),8
1571,0.4501343652485148,Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),8
1589,0.4498423290182871,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,7
697,0.44983452362674187,DAP12 signaling,38
1079,0.4497616334633067,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,18
1149,0.44909261500313413,Activation of BAD and translocation to mitochondria ,16
615,0.4490716792432722,DAP12 interactions,46
1221,0.4476258229054166,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,14
225,0.446492176579252,Interleukin-4 and Interleukin-13 signaling,111
874,0.4452244843828498,The role of Nef in HIV-1 replication and disease pathogenesis,27
1314,0.4449919641771567,TP53 Regulates Transcription of Death Receptors and Ligands,12
235,0.444536243514573,Integrin cell surface interactions,109
1024,0.444080535827197,Tie2 Signaling,20
1629,0.44323450031576933,Erythropoietin activates Phospholipase C gamma (PLCG),7
1035,0.44014973831593596,Other semaphorin interactions,20
167,0.43999381821780253,Cell-Cell communication,139
659,0.4395760370008214,Signaling by Erythropoietin,41
676,0.4395460884995807,GPVI-mediated activation cascade,40
1545,0.4394840760554919,Signaling by Overexpressed Wild-Type EGFR in Cancer,8
1577,0.4394840760554919,Inhibition of Signaling by Overexpressed EGFR,8
636,0.43879968377434964,Signaling by Retinoic Acid,43
1126,0.43797216546582923,Interleukin-27 signaling,17
1982,0.4369902571877603,TGFBR2 MSI Frameshift Mutants in Cancer,2
1090,0.43673741633789015,cGMP effects,18
875,0.43561529439394,Scavenging by Class A Receptors,27
1547,0.43551107871726863,Interleukin-18 signaling,8
1639,0.43512362596108045,Synthesis of Lipoxins (LX),6
1924,0.43399059987119754,Signaling by plasma membrane FGFR1 fusions,3
1782,0.4324679751872238,Toxicity of botulinum toxin type A (BoNT/A),4
32,0.4316069556656943,Neutrophil degranulation,477
2,0.4305826437341861,Immune System,2547
1988,0.4299976383519367,Stimulation of the cell death response by PAK-2p34,2
1048,0.42952340655852606,Transport of connexons to the plasma membrane,20
1094,0.4292811357417507,NOTCH2 intracellular domain regulates transcription,18
1776,0.42901481456423685,Cam-PDE 1 activation,4
1307,0.4280085583605466,Butyrophilin (BTN) family interactions,12
1498,0.4276708406268046,Synthesis of 5-eicosatetraenoic acids,9
1814,0.4275439752794904,Biosynthesis of D-series resolvins,4
1671,0.427090945610154,Estrogen biosynthesis,6
1272,0.426596682618046,GRB2 events in EGFR signaling,13
1207,0.4261874100728542,Eicosanoid ligand-binding receptors,15
940,0.42453456610841656,Nitric oxide stimulates guanylate cyclase,24
428,0.4238503818017154,Gap junction trafficking,69
2076,0.4227477090426588,Defective MGAT2 causes MGAT2-CDG (CDG-2a),1
2131,0.4217585698606066,"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",1
2003,0.4208692685774793,Transfer of LPS from LBP carrier to CD14,2
1492,0.4207036144060888,EGFR interacts with phospholipase C-gamma,9
1393,0.4205174683399768,ROBO receptors bind AKAP5,11
907,0.41930527362679043,Basigin interactions,25
869,0.41872276060448005,Interleukin receptor SHC signaling,27
39,0.4183491870173403,Extracellular matrix organization,418
1563,0.41606990050138415,Phase 3 - rapid repolarisation,8
935,0.4159445831566224,The canonical retinoid cycle in rods (twilight vision),24
414,0.4150192936092931,Gap junction trafficking and regulation,72
1708,0.4149074833711362,FasL/ CD95L signaling,5
1646,0.4142549555769118,Synthesis of 15-eicosatetraenoic acid derivatives,6
1775,0.4130872406119882,Reuptake of GABA,4
1870,0.41198591833977266,Biosynthesis of aspirin-triggered D-series resolvins,3
979,0.4118847981829293,RA biosynthesis pathway,22
1710,0.41181243023064534,Signaling by MST1,5
942,0.4106746873418834,Erythropoietin activates RAS,24
1728,0.41025652498011284,GRB7 events in ERBB2 signaling,5
1865,0.4087878023155522,FMO oxidises nucleophiles,3
1859,0.40831745782914003,Inositol transporters,3
1223,0.40662944557392106,Early Phase of HIV Life Cycle,14
1127,0.40624424789123575,IL-6-type cytokine receptor ligand interactions,17
1261,0.4059183190845647,Lysosphingolipid and LPA receptors,14
2143,0.4056980900756887,Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),1
1810,0.4049530130598885,RAS signaling downstream of NF1 loss-of-function variants,4
1116,0.40494281235450247,Platelet Adhesion to exposed collagen,17
291,0.4041520451180472,Interferon gamma signaling,97
479,0.4025864683055672,Arachidonic acid metabolism,62
931,0.4025361546108343,Diseases associated with the TLR signaling cascade,24
941,0.4025361546108343,Diseases of Immune System,24
1358,0.40200016772694,TP53 Regulates Transcription of Caspase Activators and Caspases,12
1422,0.40170745520707285,Reactions specific to the complex N-glycan synthesis pathway,10
2075,0.4015242057421885,Inhibition of PKR,1
2188,0.4006265533319143,Synthesis of Hepoxilins (HX) and Trioxilins (TrX),1
1304,0.40048162069031384,Purine salvage,13
1220,0.40015169264395506,SHC1 events in EGFR signaling,14
1439,0.4000249690377381,Thyroxine biosynthesis,10
2126,0.3993176452395106,Defective SLC33A1 causes spastic paraplegia 42 (SPG42),1
1021,0.3990644303398553,"Defective B4GALT7 causes EDS, progeroid type",20
1426,0.3990462714777283,Diseases associated with surfactant metabolism,10
1023,0.3989433069796067,Defective B3GALT6 causes EDSP2 and SEMDJL1,20
18,0.39850917442115363,Vesicle-mediated transport,778
1681,0.39790186790572485,Fibronectin matrix formation,6
1178,0.39698045500203855,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,15
1789,0.39643967373366407,Antagonism of Activin by Follistatin,4
1713,0.3961615150451744,Ficolins bind to repetitive carbohydrate structures on the target cell surface,5
1805,0.3960072134087365,TFAP2 (AP-2) family regulates transcription of other transcription factors,4
1022,0.39551000401949765,Defective B3GAT3 causes JDSSDHD,20
1813,0.3948825621394958,RUNX2 regulates genes involved in differentiation of myeloid cells,4
321,0.39438624691285723,Collagen formation,90
392,0.3940831727959125,Constitutive Signaling by Aberrant PI3K in Cancer,75
1760,0.3933929031595931,Reelin signalling pathway,5
1543,0.3929370320338785,Histidine catabolism,8
1249,0.3928293719317429,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",14
2210,0.3921833102172478,Defective TCN2 causes hereditary megaloblastic anemia,1
1574,0.3919603715750261,Defective CHSY1 causes TPBS,8
2114,0.39187551906314827,Retinoid metabolism disease events,1
1970,0.39145306774192085,Regulation of TP53 Expression,2
2103,0.39112803644309746,RPIA deficiency: failed conversion of R5P to RU5P,1
2102,0.39112803644309746,RPIA deficiency: failed conversion of RU5P to R5P,1
1089,0.39089826331076577,Free fatty acids regulate insulin secretion,18
1472,0.39031727862919485,Activation of PUMA and translocation to mitochondria,9
2233,0.3896736564343485,Defective PAPSS2 causes SEMD-PA,1
1020,0.3876072065201511,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,20
2134,0.38758019354996787,Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),1
625,0.3875575270028953,Sphingolipid de novo biosynthesis,44
2125,0.38748426807303143,"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",1
1132,0.38722565912199497,Acetylcholine regulates insulin secretion,17
893,0.38555476577468806,Metal ion SLC transporters,26
797,0.3853233645725071,Activation of BH3-only proteins,31
454,0.3846699184467187,"Interleukin-3, Interleukin-5 and GM-CSF signaling",66
1995,0.3840494957546861,"XAV939 inhibits tankyrase, stabilizing AXIN",2
1486,0.38393588669994877,Interleukin-9 signaling,9
2225,0.3828635461836702,Severe congenital neutropenia type 4 (G6PC3),1
1166,0.38226748323343784,Caspase activation via Death Receptors in the presence of ligand,16
300,0.38175882190676574,Post-translational modification: synthesis of GPI-anchored proteins,95
1051,0.3814870127139008,Regulation of IFNG signaling,19
1735,0.38147726969055124,TFAP2 (AP-2) family regulates transcription of cell cycle factors,5
844,0.38102678728432643,Interleukin-6 family signaling,28
1027,0.38066764286199894,VEGFR2 mediated cell proliferation,20
1036,0.37985458285357465,FGFR2 ligand binding and activation,20
2057,0.3788388715312054,MPS II - Hunter syndrome,1
1846,0.37882729132709714,Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,3
1817,0.37870719323821234,Invadopodia formation,4
1625,0.37827293475272217,Erythropoietin activates STAT5,7
662,0.37786980229705125,MET promotes cell motility,41
1721,0.37775738860781843,Biosynthesis of E-series 18(S)-resolvins,5
1449,0.3762178056517905,Zinc influx into cells by the SLC39 gene family,10
1321,0.3755021167214116,Glutathione synthesis and recycling,12
1661,0.374725267346349,Activation of caspases through apoptosome-mediated cleavage,6
771,0.3745690906354809,CD28 co-stimulation,33
1017,0.3745596607365676,Synthesis of Leukotrienes (LT) and Eoxins (EX),21
1193,0.37444843689127827,Depolymerisation of the Nuclear Lamina,15
1653,0.37387439015597906,Proton-coupled monocarboxylate transport,6
1740,0.37372752113225943,Regulation of gap junction activity,5
1247,0.37326883427201457,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",14
1244,0.37326883427201457,Defective EXT2 causes exostoses 2,14
1446,0.3730359118696785,Alpha-defensins,10
1806,0.37301554329081665,Biosynthesis of DPAn-3 SPMs,4
1834,0.37301554329081665,Biosynthesis of DPA-derived SPMs,4
1604,0.37289047460359953,tRNA processing in the mitochondrion,7
205,0.37241513913775276,Signaling by VEGF,121
1185,0.3723214574170458,Interleukin-6 signaling,15
1031,0.3715161722518225,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,20
1310,0.37107842306130356,Activation of the TFAP2 (AP-2) family of transcription factors,12
1868,0.3709366494199424,TGFBR2 Kinase Domain Mutants in Cancer,3
1907,0.3709366494199424,Loss of Function of TGFBR2 in Cancer,3
626,0.3704329191370043,Collagen chain trimerization,44
955,0.37024370781917443,Termination of O-glycan biosynthesis,23
826,0.369682718816806,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,30
821,0.369682718816806,Neurodegenerative Diseases,30
1584,0.3694505052190743,RUNX3 regulates CDKN1A transcription,7
1481,0.3693869656362482,Prostanoid ligand receptors,9
1759,0.36936553569065084,MECP2 regulates transcription factors,5
1192,0.3688621221901415,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,15
1007,0.368281371024935,CTLA4 inhibitory signaling,21
1290,0.3681837723236803,Retinoid cycle disease events,13
1298,0.3681837723236803,Diseases associated with visual transduction,13
2228,0.3679428620235427,PTEN Loss of Function in Cancer,1
1372,0.3675115673795926,MET activates RAS signaling,11
671,0.3674134601241861,Detoxification of Reactive Oxygen Species,40
993,0.3669682440601699,CD209 (DC-SIGN) signaling,21
1169,0.3662940254694137,Condensation of Prometaphase Chromosomes,16
900,0.3662591459650077,CRMPs in Sema3A signaling,25
1475,0.36555211821292904,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,9
968,0.36533985043010675,CD28 dependent PI3K/Akt signaling,22
1754,0.36508890757548224,Abacavir transmembrane transport,5
1194,0.36473403261364906,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,15
2107,0.3643500061607189,"Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2",1
9,0.36414205689005247,Developmental Biology,1350
1579,0.36362042020114704,Defective CHST3 causes SEDCJD,8
221,0.3633274583903002,VEGFA-VEGFR2 Pathway,113
1215,0.3624738741900281,Constitutive Signaling by EGFRvIII,14
1233,0.3624738741900281,Signaling by EGFRvIII in Cancer,14
1251,0.36241536715271544,Mitotic Telophase/Cytokinesis,14
1195,0.36239159050099423,GRB2:SOS provides linkage to MAPK signaling for Integrins ,15
1125,0.36189362921851664,Zinc transporters,17
1711,0.3614063325306174,APOBEC3G mediated resistance to HIV-1 infection,5
1811,0.36076457655141636,"TET1,2,3 and TDG demethylate DNA",4
751,0.36067711882007647,Syndecan interactions,34
166,0.3605873367714887,Rho GTPase cycle,139
782,0.3603423680868262,G-protein beta:gamma signalling,32
2147,0.3602552522396759,Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),1
644,0.35998712006628486,HS-GAG biosynthesis,43
630,0.3596911621297952,TP53 Regulates Transcription of Cell Death Genes,44
827,0.3588893907591287,MET activates PTK2 signaling,30
731,0.35834155637249826,Adherens junctions interactions,36
1381,0.358107652454825,Signaling by FGFR4 in disease,11
1897,0.3576791859292965,Adrenaline signalling through Alpha-2 adrenergic receptor,3
1576,0.3575448771985358,"Defective CHST14 causes EDS, musculocontractural type",8
1313,0.35717706105525465,Reversible hydration of carbon dioxide,12
1404,0.3571559873544906,Regulation of gene expression by Hypoxia-inducible Factor,11
682,0.3570854611712183,Synthesis of PA,39
1878,0.35561515500094987,Ceramide signalling,3
2013,0.3547359817690541,Glycogen storage disease type 0 (liver GYS2),2
1308,0.3544418335347017,CLEC7A (Dectin-1) induces NFAT activation,12
1635,0.35430556808430697,Intestinal absorption,6
1975,0.35412297226922596,Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,2
1977,0.35412297226922596,Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,2
895,0.3537630877001158,Synthesis of IP3 and IP4 in the cytosol,26
1827,0.35364219923511214,Biosynthesis of E-series 18(R)-resolvins,4
813,0.3530712347530496,Surfactant metabolism,30
1355,0.3530208492171191,Miscellaneous substrates,12
1491,0.3529661970842192,Scavenging by Class B Receptors,9
932,0.3528221646932568,Signaling by EGFR in Cancer,24
881,0.3520755279511895,Interleukin-20 family signaling,26
2160,0.3518729842694692,Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3),1
2161,0.3518729842694692,Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3),1
1540,0.35183875343774085,IRF3 mediated activation of type 1 IFN,8
950,0.35159386190354214,Nucleotide salvage,23
262,0.35142926916043177,PI3K/AKT Signaling in Cancer,102
738,0.35122560612446235,Regulation of signaling by CBL,35
397,0.35098172436125447,Non-integrin membrane-ECM interactions,73
1373,0.3502231686716373,MET activates RAP1 and RAC1,11
1157,0.35000887200668857,Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),16
1980,0.34935131580065887,UNC93B1 deficiency - HSE,2
1088,0.34929988923304134,ABC transporters in lipid homeostasis,18
1431,0.348711332980966,Urea cycle,10
2017,0.34831801170270604,phospho-PLA2 pathway,2
1875,0.3472048737603637,Glycogen storage disease type IV (GBE1),3
1718,0.34720183126199466,Diseases of Mismatch Repair (MMR),5
1183,0.3468993737826939,WNT5A-dependent internalization of FZD4,15
1737,0.34687164581055663,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,5
1468,0.34684263751876016,TRIF-mediated programmed cell death,9
880,0.3464854152820379,N-glycan antennae elongation in the medial/trans-Golgi,26
1398,0.3464596318626892,Aspartate and asparagine metabolism,11
1154,0.34610690823065143,Rap1 signalling,16
883,0.34581566522860147,Miscellaneous transport and binding events,26
1774,0.34519768228116443,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,4
1161,0.34340097082452437,Defective GALNT12 causes colorectal cancer 1 (CRCS1),16
1969,0.3432567721324901,NFG and proNGF binds to p75NTR,2
143,0.3431966527272075,Toll-like Receptor Cascades,158
1327,0.3430793369363276,Scavenging by Class F Receptors,12
1377,0.3421996142711647,Dermatan sulfate biosynthesis,11
1534,0.34186063764260705,Linoleic acid (LA) metabolism,8
86,0.34183455497681503,G alpha (q) signalling events,227
1586,0.34143052002812524,Zinc efflux and compartmentalization by the SLC30 family,7
1257,0.34121839639627866,Regulation of TP53 Activity through Association with Co-factors,14
1288,0.34094810354430655,Passive transport by Aquaporins,13
1128,0.34079679001098906,GAB1 signalosome,17
260,0.3398704770844288,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",103
1930,0.3397856058820954,Plasmalogen biosynthesis,3
203,0.33887678291275536,TCR signaling,122
515,0.33839404226544645,Signaling by PDGF,58
1356,0.33821927675379465,Role of ABL in ROBO-SLIT signaling,12
1695,0.3381837224898234,Synthesis of PI,5
922,0.3381822707686235,Cytosolic sulfonation of small molecules,24
2169,0.33804280887754096,Defective ACY1 causes encephalopathy,1
1296,0.3374710211510227,ERBB2 Activates PTK6 Signaling,13
509,0.3374601527013612,Elastic fibre formation,59
913,0.3373774359908287,Triglyceride catabolism,25
858,0.3372665046785387,Inflammasomes,28
972,0.33711674162312305,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,22
109,0.33671349932494055,Peptide ligand-binding receptors,188
1881,0.33662311233444275,RUNX3 regulates RUNX1-mediated transcription,3
1433,0.33638792968718567,Adenylate cyclase activating pathway,10
195,0.33618267429595855,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),124
1504,0.33582890754667016,Ca2+ activated K+ channels,9
960,0.3355506834082338,RAF-independent MAPK1/3 activation,23
1059,0.33541741313077406,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,19
231,0.3354106364736677,Negative regulation of the PI3K/AKT network,110
1001,0.3353593619235521,Signal transduction by L1,21
573,0.3347725387753926,Molecules associated with elastic fibres,52
872,0.33458460828323616,Integrin signaling,27
873,0.33458460828323616,Integrin alphaIIb beta3 signaling,27
1138,0.3345023517330691,Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),17
1669,0.3337774779430702,Biosynthesis of EPA-derived SPMs,6
1532,0.3336412576349429,RNF mutants show enhanced WNT signaling and proliferation,8
593,0.3332074051384361,TP53 Regulates Transcription of Cell Cycle Genes,49
1309,0.3325078385323036,Regulation of commissural axon pathfinding by SLIT and ROBO,12
1608,0.3322391878607133,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,7
1593,0.3322391878607133,Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,7
62,0.33198908395814314,"Platelet activation, signaling and aggregation",294
677,0.33190062388063774,NOTCH3 Intracellular Domain Regulates Transcription,40
2071,0.3316934214238599,Metabolism of ingested MeSeO2H into MeSeH,1
1483,0.33155784960340084,Nef Mediated CD4 Down-regulation,9
897,0.33128408425962036,A tetrasaccharide linker sequence is required for GAG synthesis,26
1521,0.3310389616327932,RUNX3 regulates YAP1-mediated transcription,8
23,0.330890866509878,Signaling by Interleukins,699
860,0.33085775654387056,Insulin processing,28
2050,0.33059796202351205,MPS IIID - Sanfilippo syndrome D,1
1208,0.3304329921831731,p130Cas linkage to MAPK signaling for integrins,15
1597,0.3302444786293125,Activated NTRK2 signals through PI3K,7
1427,0.3292649531955128,MAPK3 (ERK1) activation,10
865,0.3292388298470715,Caspase activation via extrinsic apoptotic signalling pathway,27
439,0.3291775117713304,Cell-cell junction organization,68
1785,0.329109931046254,Amine Oxidase reactions,4
52,0.3282934184670252,Class A/1 (Rhodopsin-like receptors),320
1131,0.32811622413394376,Activated NTRK2 signals through FRS2 and FRS3,17
698,0.327396034054396,Defective B3GALTL causes Peters-plus syndrome (PpS),38
991,0.3270001508242,Interleukin-37 signaling,21
608,0.3264813328277091,DAG and IP3 signaling,47
2091,0.32600687702525477,Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS),1
1767,0.32579530588882233,SLIT2:ROBO1 increases RHOA activity,4
1648,0.3256278705922036,Protein repair,6
15,0.32551779697620503,Cytokine Signaling in Immune system,961
1049,0.3255086862307474,RIPK1-mediated regulated necrosis,20
1047,0.3255086862307474,Regulated Necrosis,20
1179,0.32523240240188306,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,15
524,0.32506734071037363,Intrinsic Pathway for Apoptosis,58
1873,0.3247359189810192,FGFR1c and Klotho ligand binding and activation,3
1237,0.32450730236038633,CaMK IV-mediated phosphorylation of CREB,14
1086,0.32442852163015945,Regulation of necroptotic cell death,18
1176,0.32422847773764374,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,15
1575,0.3241290219661691,Defective CHST6 causes MCDC1,8
912,0.32385955484800893,G beta:gamma signalling through PI3Kgamma,25
2087,0.3234244274918983,Defective SLC6A2 causes orthostatic intolerance (OI),1
117,0.3229774781538183,Apoptosis,182
1407,0.3228961116015817,CASP8 activity is inhibited,11
1387,0.3228961116015817,Regulation by c-FLIP,11
1400,0.3228961116015817,Dimerization of procaspase-8,11
1056,0.3223715643664066,Metabolism of Angiotensinogen to Angiotensins,19
624,0.32224866993256024,WNT ligand biogenesis and trafficking,45
1409,0.32200210130178486,Pyrimidine salvage,11
106,0.3219596653207331,Programmed Cell Death,189
1965,0.3210774183552232,MyD88 deficiency (TLR5),2
347,0.32093918344003775,Semaphorin interactions,85
1440,0.32093114297953046,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",10
1773,0.3207404250156056,Regulation of cortical dendrite branching,4
1896,0.32069885432261164,Adenosine P1 receptors,3
1928,0.3200837607164014,PKB-mediated events,3
1869,0.3200837607164014,PDE3B signalling,3
181,0.3199684418786742,Response to elevated platelet cytosolic Ca2+,132
1124,0.31995154372928913,Sema3A PAK dependent Axon repulsion,17
687,0.3197045423349621,O-glycosylation of TSR domain-containing proteins,39
449,0.3194598781692614,Collagen biosynthesis and modifying enzymes,67
643,0.3192480936363929,Ca-dependent events,43
369,0.3190851831957128,Signaling by MET,80
839,0.3187389395245286,Downstream signal transduction,29
1320,0.3183181925090864,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,12
367,0.31827507621424656,G alpha (12/13) signalling events,80
323,0.31824767663114745,ECM proteoglycans,90
1493,0.31804207130332873,MAPK1 (ERK2) activation,9
665,0.3178300488526703,Calmodulin induced events,41
664,0.3178300488526703,CaM pathway,41
971,0.31769920897379683,Signaling by FGFR3 in disease,22
970,0.31769920897379683,Signaling by FGFR3 point mutants in cancer,22
863,0.3176677872354848,VEGFR2 mediated vascular permeability,27
901,0.3174210398337252,Synthesis of very long-chain fatty acyl-CoAs,25
2009,0.31723279695386386,Alanine metabolism,2
2224,0.31698804825595167,Defective BTD causes biotidinase deficiency,1
1494,0.31691144185117115,Activated NTRK2 signals through RAS,9
981,0.31680528751126785,GRB2 events in ERBB2 signaling,22
1631,0.3164554072587927,Uptake and function of diphtheria toxin,6
1554,0.3161398846577393,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),8
371,0.3159944586172138,Extra-nuclear estrogen signaling,80
878,0.3159754003426997,Endogenous sterols,27
497,0.31576867410930815,NRAGE signals death through JNK,60
977,0.31537302440767323,RORA activates gene expression,22
1872,0.31533783823119993,Breakdown of the nuclear lamina,3
1389,0.31517527679791435,Endosomal/Vacuolar pathway,11
2105,0.31490772168126496,Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF,1
2064,0.314853639426016,NADPH regeneration,1
2045,0.314853639426016,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,1
1792,0.31484650021239324,Loss of phosphorylation of MECP2 at T308,4
2062,0.31467549396173083,MGMT-mediated DNA damage reversal,1
191,0.3145584023623377,Platelet degranulation ,127
581,0.31447161258177136,Retinoid metabolism and transport,51
1300,0.31413972948282637,Activation of RAC1,13
620,0.31361208810026503,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,45
680,0.3135380742823691,Triglyceride metabolism,39
1037,0.3131637878186898,Chondroitin sulfate biosynthesis,20
1618,0.31314406160792313,Phase 1 - inactivation of fast Na+ channels,7
1147,0.31299041641500397,Elevation of cytosolic Ca2+ levels,16
1610,0.3125324599028852,NrCAM interactions,7
1617,0.3123828185576563,FGFR3b ligand binding and activation,7
446,0.31218661140022325,Heparan sulfate/heparin (HS-GAG) metabolism,67
592,0.3120099274569618,EPHA-mediated growth cone collapse,49
1637,0.3119323584579467,Sensing of DNA Double Strand Breaks,6
1010,0.3117086592918082,"Cobalamin (Cbl, vitamin B12) transport and metabolism",21
1801,0.31160519575368206,LDL remodeling,4
1484,0.31160145347632034,Nef mediated downregulation of MHC class I complex cell surface expression,9
27,0.3115906267904942,Signaling by Receptor Tyrosine Kinases,553
2221,0.3115894691867402,Signaling by FGFR1 amplification mutants,1
1378,0.3110413009265737,SOS-mediated signalling,11
788,0.3109425537352575,TRAF6 mediated NF-kB activation,32
1652,0.31093463786244524,Lipid particle organization,6
1370,0.31078158288536684,"SMAC, XIAP-regulated apoptotic response",11
1824,0.31072987245360384,Mitochondrial ABC transporters,4
785,0.31072752187371944,Growth hormone receptor signaling,32
1334,0.31052346460126007,Pyrimidine catabolism,12
670,0.31034166702140886,Signaling by NOTCH2,40
1603,0.3100690717441362,CREB phosphorylation,7
1536,0.3099097323959215,Defective ST3GAL3 causes MCT12 and EIEE15,8
242,0.3095667502965945,Post-translational protein phosphorylation,107
817,0.3094956627234351,Tight junction interactions,30
984,0.30934840588686197,HS-GAG degradation,22
417,0.3093331695987949,Interleukin-12 family signaling,71
1513,0.30898444760380434,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),9
879,0.30873676706319625,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,27
33,0.3086759035844045,G alpha (i) signalling events,469
1702,0.3086340327524413,Muscarinic acetylcholine receptors,5
689,0.3082399145814018,Platelet Aggregation (Plug Formation),39
851,0.3076347423560613,Platelet calcium homeostasis,28
534,0.3075360698402936,Ion transport by P-type ATPases,55
1668,0.3074086814120895,PKA-mediated phosphorylation of key metabolic factors,6
500,0.307401394927275,Iron uptake and transport,60
1155,0.3071009097348979,TRAF6-mediated induction of TAK1 complex within TLR4 complex,16
340,0.3069792751418054,Signaling by FGFR,87
552,0.30690892429380773,Thrombin signalling through proteinase activated receptors (PARs),54
663,0.3068686133489664,Diseases associated with glycosaminoglycan metabolism,41
326,0.3067770426912533,Ca2+ pathway,90
1065,0.30673630362669363,Aflatoxin activation and detoxification,19
1240,0.3065493146382036,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,14
857,0.30636976068950517,Signaling by BMP,28
1324,0.30618197857465707,Ethanol oxidation,12
1218,0.30614906012248433,CS/DS degradation,14
1505,0.3060468670270192,SMAC (DIABLO) binds to IAPs ,9
1511,0.3060468670270192,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,9
506,0.30578794932390296,Ion homeostasis,59
332,0.3057211737853539,Sphingolipid metabolism,89
204,0.3054140965150132,MHC class II antigen presentation,122
675,0.3053098996391248,RET signaling,40
364,0.30504205029207654,G-protein mediated events,81
718,0.3050049283531053,ROS and RNS production in phagocytes,36
1198,0.3047870304041934,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),15
435,0.3045863181592769,Diseases associated with O-glycosylation of proteins,68
1570,0.3045481171938586,TRAIL  signaling,8
1677,0.3044563738492836,FGFR1b ligand binding and activation,6
1165,0.30440928422244884,Regulation of pyruvate dehydrogenase (PDH) complex,16
1779,0.30438624147485127,AKT-mediated inactivation of FOXO1A,4
1085,0.304236446724286,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,18
1095,0.304236446724286,Signaling by Ligand-Responsive EGFR Variants in Cancer,18
2031,0.30406589711944915,NTF4 activates NTRK2 (TRKB) signaling,2
764,0.30403462912652984,Cargo concentration in the ER,33
896,0.3036073940343585,NOTCH4 Intracellular Domain Regulates Transcription,26
240,0.3034530688513647,Platelet homeostasis,107
1016,0.3033218951904504,Regulation of FZD by ubiquitination,21
1346,0.30323285890209967,Tandem pore domain potassium channels,12
29,0.30283149315207053,Signaling by Rho GTPases,511
226,0.3028208635640254,O-linked glycosylation,111
1962,0.3025326110427712,TICAM1 deficiency - HSE,2
916,0.3020210970394434,Downstream signaling of activated FGFR3,25
811,0.30179109347909044,RHO GTPases activate IQGAPs,31
464,0.30163759759703124,EPH-ephrin mediated repulsion of cells,65
1757,0.30152796112746016,Toxicity of botulinum toxin type D (BoNT/D),5
1756,0.30152796112746016,Toxicity of botulinum toxin type F (BoNT/F),5
1245,0.3011487744051143,LGI-ADAM interactions,14
419,0.30109278131856737,Translocation of SLC2A4 (GLUT4) to the plasma membrane,71
1476,0.30093979561731155,Multifunctional anion exchangers,9
1531,0.3009246131835595,Lectin pathway of complement activation,8
539,0.3008621701513555,Metabolism of fat-soluble vitamins,55
1069,0.3007453019537882,The NLRP3 inflammasome,19
418,0.3006271377012162,PLC beta mediated events,71
1136,0.3006201519046426,Hyaluronan metabolism,17
1248,0.30057599109534466,Tryptophan catabolism,14
1345,0.3004938436108044,Reduction of cytosolic Ca++ levels,12
1173,0.30036236329443017,Calcineurin activates NFAT,16
1187,0.3003260331298735,N-Glycan antennae elongation,15
597,0.3000937195951719,Inositol phosphate metabolism,48
1093,0.2992099441834116,PI-3K cascade:FGFR3,18
1568,0.2992077742323717,Netrin mediated repulsion signals,8
1421,0.2992059104197634,RUNX2 regulates genes involved in cell migration,10
1508,0.29907069986113394,Sodium/Proton exchangers,9
496,0.29874093193017315,G alpha (z) signalling events,60
540,0.2983304668588927,Interleukin-12 signaling,55
1038,0.29810845583198187,FRS-mediated FGFR3 signaling,20
951,0.29806043576765245,Thromboxane signalling through TP receptor,23
363,0.2977684200809281,Oncogenic MAPK signaling,81
448,0.29773512882764447,RHO GTPases Activate WASPs and WAVEs,67
342,0.2974484713279515,"Transport of bile salts and organic acids, metal ions and amine compounds",86
587,0.29682453325064734,Signaling by EGFR,50
1331,0.29666525874953287,SHC-related events triggered by IGF1R,12
1541,0.2964941226319441,Phosphate bond hydrolysis by NTPDase proteins,8
2052,0.2964005761200134,MPS IIIB - Sanfilippo syndrome B,1
1777,0.29612119686446065,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,4
477,0.29608230916954,O-linked glycosylation of mucins,62
2135,0.29604112348907347,Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF),1
864,0.29603548920832606,FGFR2 alternative splicing,27
361,0.295816037034142,FOXO-mediated transcription,81
1587,0.2957358597367823,STAT5 Activation,7
1733,0.2956885388611389,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,5
1569,0.29555701160338216,Interleukin-1 processing,8
398,0.295511970120768,Signaling by FGFR2,73
989,0.29525140612046824,Post-chaperonin tubulin folding pathway,22
937,0.29507382606467586,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,24
1083,0.29499426181814026,G beta:gamma signalling through BTK,18
466,0.29495705323082344,RAB geranylgeranylation,65
876,0.2948577693114237,Effects of PIP2 hydrolysis,27
763,0.2947237845073591,Sialic acid metabolism,33
1184,0.2945923142789574,Fatty acids,15
1391,0.2945717183132821,eNOS activation,11
1942,0.29438404634409954,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),2
1253,0.294284581426093,Regulation of FOXO transcriptional activity by acetylation,14
1282,0.29369516864650785,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",13
522,0.2936931704620655,Signaling by RAS mutants,58
1428,0.29358496146479085,HDL remodeling,10
254,0.2933285316390423,TNFR2 non-canonical NF-kB pathway,104
684,0.29330317164317105,Formation of Fibrin Clot (Clotting Cascade),39
461,0.2930733581355463,Signaling by BRAF and RAF fusions,65
274,0.2929101858860825,Downstream TCR signaling,99
1305,0.2926568323978777,Dissolution of Fibrin Clot,13
348,0.29261295545207533,TP53 Regulates Metabolic Genes,85
1459,0.292604755212828,MET receptor recycling,10
990,0.2921633328474772,PKA-mediated phosphorylation of CREB,22
1114,0.2918832116391073,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,17
1034,0.2916526091645276,Chaperone Mediated Autophagy,20
36,0.2916364370971716,GPCR ligand binding,453
1081,0.29115434500111925,Crosslinking of collagen fibrils,18
442,0.2911016589434748,Signaling by ERBB2,68
887,0.2908606425172974,Formation of tubulin folding intermediates by CCT/TriC,26
440,0.2907534190828046,Kinesins,68
176,0.2898165624716333,Glycerophospholipid biosynthesis,133
1948,0.28961879762652254,Biosynthesis of DPAn-6 SPMs,2
1271,0.28955156828747924,Synthesis of PE,13
641,0.28951563843122297,Vasopressin regulates renal water homeostasis via Aquaporins,43
1115,0.28936043243716564,Platelet sensitization by LDL,17
2002,0.28929800024530533,Pentose phosphate pathway disease,2
1273,0.28922835043010664,The activation of arylsulfatases,13
172,0.28917384601992696,Glycosaminoglycan metabolism,136
544,0.2890569580264472,Signaling by PTK6,55
542,0.2890569580264472,Signaling by Non-Receptor Tyrosine Kinases,55
994,0.2888273009038818,Presynaptic function of Kainate receptors,21
1862,0.2887892413900554,"Formation of the active cofactor, UDP-glucuronate",3
1322,0.2885901216210574,CREB3 factors activate genes,12
251,0.2882046868640512,Phase I - Functionalization of compounds,105
84,0.28791691301257877,Interferon Signaling,228
1893,0.28762938293688606,Proline catabolism,3
586,0.28739420000493904,Chondroitin sulfate/dermatan sulfate metabolism,50
1259,0.2873263793534781,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,14
1262,0.2873263793534781,alpha-linolenic acid (ALA) metabolism,14
1091,0.28729387325937145,SHC-mediated cascade:FGFR3,18
1026,0.28727286868600943,Signaling by Hippo,20
1501,0.28679406736750257,OAS antiviral response,9
1564,0.28652244065458454,Chylomicron clearance,8
1802,0.28632199084189297,TGFBR1 LBD Mutants in Cancer,4
1795,0.28616895912634227,PLCG1 events in ERBB2 signaling,4
1684,0.2860069168664678,RUNX1 regulates transcription of genes involved in WNT signaling,6
481,0.28594993398884583,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),61
1598,0.28592275356438923,Aryl hydrocarbon receptor signalling,7
1151,0.2852851511165531,Cytochrome c-mediated apoptotic response,16
561,0.2852489703366335,Synthesis of PIPs at the plasma membrane,53
1145,0.28512067497334015,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,16
1399,0.28503389678370855,RHO GTPases activate KTN1,11
180,0.2848308111107008,Toll Like Receptor 4 (TLR4) Cascade,132
1032,0.284662261151805,G beta:gamma signalling through PLC beta,20
1542,0.28432285086449394,Sema4D mediated inhibition of cell attachment and migration,8
818,0.28424120989919754,Downstream signaling of activated FGFR2,30
647,0.28418237354619275,NCAM1 interactions,43
1182,0.2841573624757861,CREB1 phosphorylation through the activation of Adenylate Cyclase,15
804,0.2837739125584159,EGFR downregulation,31
855,0.2833242452373538,Prefoldin mediated transfer of substrate  to CCT/TriC,28
556,0.28332281939153603,Signal amplification,54
1530,0.28324982152613254,Activated NTRK3 signals through RAS,8
1463,0.28319159998136695,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),9
394,0.2828022337119188,NCAM signaling for neurite out-growth,74
1277,0.28240906728530574,Lipophagy,13
1104,0.2823048459437126,Signaling by Activin,18
557,0.282214577255144,IRS-mediated signalling,54
2206,0.282197055656871,Deletions in the AMER1 gene destabilize the destruction complex,1
44,0.2821954232617921,RHO GTPase Effectors,382
89,0.2820248342766417,Phospholipid metabolism,222
1117,0.2814947993905017,PKA activation in glucagon signalling,17
571,0.28078666045424094,Aquaporin-mediated transport,52
2211,0.2806213154866454,Defective FMO3 causes Trimethylaminuria (TMAU),1
2202,0.28060302765878825,"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)",1
1033,0.28030099235285194,G beta:gamma signalling through CDC42,20
1812,0.28025747440235843,Biosynthesis of protectins,4
1510,0.28012365637940895,Small interfering RNA (siRNA) biogenesis,9
1923,0.279936249981533,Electron transport from NADPH to Ferredoxin,3
1628,0.27992336269397294,Glycerophospholipid catabolism,7
1284,0.2795847814424774,FGFR3 ligand binding and activation,13
1285,0.2795847814424774,FGFR3c ligand binding and activation,13
196,0.27955640244371377,Visual phototransduction,123
703,0.27898290938405856,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,38
2122,0.2788308930651559,Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),1
1724,0.27862019302648033,G2 Phase,5
967,0.2785541573363633,Intrinsic Pathway of Fibrin Clot Formation,22
605,0.27848036170663615,ADP signalling through P2Y purinoceptor 1,47
1012,0.27821066870006395,Negative regulation of NMDA receptor-mediated neuronal transmission,21
1828,0.27807788395306476,"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",4
458,0.27791496256119363,Cytochrome P450 - arranged by substrate type,65
249,0.2775733513077817,Cargo recognition for clathrin-mediated endocytosis,105
915,0.2775551195051792,FRS-mediated FGFR2 signaling,25
451,0.2772678773275654,Signaling by FGFR in disease,66
1797,0.2772428015404945,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,4
212,0.277077308658165,Opioid Signalling,118
60,0.2768253326054348,Other interleukin signaling,297
953,0.2766299072300545,PI-3K cascade:FGFR2,23
780,0.276375138182811,Amino acid transport across the plasma membrane,33
465,0.27635107974728695,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",65
1119,0.2761293869293047,PKA activation,17
1275,0.2760354177190369,Signaling by Leptin,13
68,0.2757574209160396,Signaling by Nuclear Receptors,270
160,0.2750741910827442,Cardiac conduction,144
1148,0.27503906163712494,Interleukin-23 signaling,16
1164,0.2750322800950244,YAP1- and WWTR1 (TAZ)-stimulated gene expression,16
1549,0.2749988895452702,Synthesis of UDP-N-acetyl-glucosamine,8
1325,0.2749403868224975,Transport of organic anions,12
413,0.2749343085744329,Signaling by NOTCH3,72
114,0.27491520235409445,Fatty acid metabolism,183
132,0.27488633912678806,L1CAM interactions,168
1097,0.2748706005547812,Lewis blood group biosynthesis,18
1429,0.2747840996131938,Calcitonin-like ligand receptors,10
562,0.2740781846333712,Nuclear Envelope Breakdown,53
1922,0.27396279079624675,Potassium transport channels,3
616,0.2739560178285126,Signaling by moderate kinase activity BRAF mutants,45
621,0.2739560178285126,Paradoxical activation of RAF signaling by kinase inactive BRAF,45
1238,0.2738463399313193,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,14
720,0.2737826036954029,Metabolic disorders of biological oxidation enzymes,36
1879,0.2737143596071284,Mitochondrial transcription initiation,3
213,0.2736468990702917,Regulation of insulin secretion,118
727,0.2734893274686601,Signaling by high-kinase activity BRAF mutants,36
514,0.2734170228522632,IRS-related events triggered by IGF1R,58
729,0.2732816440531035,Nucleobase catabolism,36
61,0.2732194566557273,MAPK family signaling cascades,296
366,0.2731618229845193,"Cell death signalling via NRAGE, NRIF and NADE",81
1423,0.27292199149874136,PI3K events in ERBB4 signaling,10
73,0.272705914078006,MAPK1/MAPK3 signaling,253
1078,0.27265399666268403,Metabolism of amine-derived hormones,18
162,0.2726031447953495,Diseases of glycosylation,143
66,0.2725500588132075,FLT3 Signaling,274
1058,0.2725407350354886,Na+/Cl- dependent neurotransmitter transporters,19
2217,0.2724468388150789,Defective ALG8 causes ALG8-CDG (CDG-1h),1
1478,0.27227136425940424,Adrenoceptors,9
75,0.2720923149870767,RAF/MAP kinase cascade,247
795,0.2720101783945156,Nicotinate metabolism,31
1099,0.2719448894014315,Signaling by cytosolic FGFR1 fusion mutants,18
728,0.27179238155739693,RHO GTPases activate PAKs,36
854,0.271726026676489,Activation of AMPK downstream of NMDARs,28
188,0.27164936162297415,EPH-Ephrin signaling,130
595,0.2716084006523251,Assembly and cell surface presentation of NMDA receptors,48
532,0.27151655797296165,HSP90 chaperone cycle for steroid hormone receptors (SHR),56
799,0.2713885303140945,Transcription of E2F targets under negative control by DREAM complex,31
1267,0.2709677855172627,Triglyceride biosynthesis,14
1135,0.27087616317355073,Formation of Senescence-Associated Heterochromatin Foci (SAHF),17
153,0.27053342910204686,C-type lectin receptors (CLRs),147
192,0.2703152258672051,Activation of NMDA receptors and postsynaptic events,127
322,0.27031452267236333,PI Metabolism,90
1622,0.27008023505534057,Post-transcriptional silencing by small RNAs,7
266,0.270048913641911,Toll Like Receptor TLR1:TLR2 Cascade,102
263,0.270048913641911,Toll Like Receptor 2 (TLR2) Cascade,102
306,0.26999891688626687,Post NMDA receptor activation events,94
1473,0.26956957795257996,InlA-mediated entry of Listeria monocytogenes into host cells,9
982,0.2695062768766423,Apoptotic factor-mediated response,22
1216,0.269440267777994,SHC1 events in ERBB4 signaling,14
43,0.2694031051199073,Diseases of signal transduction,389
613,0.26923715467291964,PI3K Cascade,46
1167,0.2691931689693262,PI3K events in ERBB2 signaling,16
1627,0.2691353674487804,Nef Mediated CD8 Down-regulation,7
17,0.26902784914690225,Metabolism of lipids,781
1753,0.2690070419015715,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,5
152,0.26865428950456033,Death Receptor Signalling,149
822,0.2686196547305302,Activation of kainate receptors upon glutamate binding,30
669,0.26835976497991104,G0 and Early G1,41
674,0.26821478302505286,MAP2K and MAPK activation,40
948,0.26730428650689264,SHC-mediated cascade:FGFR2,23
24,0.2671772956782381,Membrane Trafficking,668
1963,0.26712027160048957,Hydrolysis of LPE,2
483,0.26706922119067,Insulin receptor signalling cascade,61
1318,0.2670621908042789,ARMS-mediated activation,12
407,0.26661326021697596,AURKA Activation by TPX2,72
632,0.2664584124492247,Cyclin D associated events in G1,44
631,0.2664584124492247,G1 Phase,44
1417,0.26639486020990455,RUNX3 regulates p14-ARF,10
495,0.26618201618988013,IGF1R signaling cascade,60
2060,0.2658403909859329,Minus-strand DNA synthesis,1
2069,0.2658403909859329,Uncoating of the HIV Virion,1
2158,0.2658403909859329,Plus-strand DNA synthesis,1
2090,0.2658403909859329,Reverse Transcription of HIV RNA,1
430,0.26581145152546676,Loss of proteins required for interphase microtubule organization from the centrosome,69
424,0.26581145152546676,Loss of Nlp from mitotic centrosomes,69
476,0.2656734982184159,Interleukin-7 signaling,63
2000,0.26544586678696735,Regulation of PAK-2p34 activity by PS-GAP/RHG10,2
791,0.26538086465082217,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,32
277,0.2652575799879762,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,99
278,0.2652575799879762,Toll Like Receptor TLR6:TLR2 Cascade,99
843,0.2651529606985687,TRP channels,28
307,0.2651001948439443,Class B/2 (Secretin family receptors),94
656,0.26500119542704975,Smooth Muscle Contraction,42
739,0.2648989236658694,Glutathione conjugation,35
892,0.2647840931288997,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),26
1137,0.26471867766671436,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,17
1578,0.264717196447504,Inactivation of CDC42 and RAC1,8
685,0.2647095360363196,Fatty acyl-CoA biosynthesis,39
1052,0.26447899800839,Nicotinamide salvaging,19
1120,0.2644737831296202,Trafficking of GluR2-containing AMPA receptors,17
1055,0.2644489270414347,"Synthesis, secretion, and deacylation of Ghrelin",19
2174,0.26439663982547684,PI and PC transport between ER and Golgi membranes,1
1689,0.26436838312594985,RUNX2 regulates chondrocyte maturation,5
325,0.26418926987855007,RAB GEFs exchange GTP for GDP on RABs,90
762,0.26412457942311374,Metabolism of steroid hormones,34
1697,0.26405554058378045,RUNX3 regulates BCL2L11 (BIM) transcription,5
1225,0.26387272445051,Formation of apoptosome,14
1265,0.26387272445051,Regulation of the apoptosome activity,14
115,0.26383009608656566,Ion channel transport,183
1674,0.2637911911481742,Phenylalanine metabolism,6
158,0.2636552575880794,Clathrin-mediated endocytosis,145
1061,0.2636347663723865,Phase 4 - resting membrane potential,19
1871,0.26351766919367997,Integration of viral DNA into host genomic DNA,3
1867,0.26351766919367997,Autointegration results in viral DNA circles,3
1527,0.2633262522757085,rRNA modification in the mitochondrion,8
800,0.2632468656304223,Transcriptional regulation of pluripotent stem cells,31
1690,0.26319059807388107,Synthesis of PIPs at the ER membrane,5
469,0.26318029909443647,EPHB-mediated forward signaling,64
673,0.2630717656913325,Negative regulators of DDX58/IFIH1 signaling,40
1451,0.26305870002677756,Abacavir transport and metabolism,10
781,0.26260649343415654,Microautophagy,32
1900,0.2618978337957342,Activation of BIM and translocation to mitochondria ,3
803,0.26189335413012815,Downstream signaling of activated FGFR1,31
1819,0.26145569615034076,Ion influx/efflux at host-pathogen interface,4
93,0.26142804772545863,Muscle contraction,216
1018,0.2613715169803433,Synthesis of PIPs at the early endosome membrane,20
1664,0.2613447211225268,CLEC7A/inflammasome pathway,6
862,0.2612517018626652,Listeria monocytogenes entry into host cells,27
95,0.26122872518498913,Mitotic Prometaphase,206
245,0.2612272526129805,Transport of inorganic cations/anions and amino acids/oligopeptides,106
140,0.261196456292471,Integration of energy metabolism,160
164,0.2610972766836236,Interleukin-1 family signaling,140
1003,0.2610882548227353,Signaling by NTRK3 (TRKC),21
700,0.26095305096939164,Signaling by FGFR1 in disease,38
1299,0.2608627867188822,Initiation of Nuclear Envelope Reformation,13
1278,0.2608627867188822,Nuclear Envelope Reassembly,13
638,0.2606404310666843,TNF signaling,43
1015,0.25996350274853813,Negative regulation of MET activity,21
1816,0.25966175823740595,Activation of AMPA receptors,4
1199,0.25920044787684254,Synthesis of PIPs at the late endosome membrane,15
463,0.25917712265191817,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,65
930,0.2591325429393054,RHO GTPases Activate ROCKs,24
1518,0.25910295232499236,Activated NTRK2 signals through PLCG1,8
672,0.2590069514892729,Signaling by FGFR3,40
1567,0.2588659913118382,Binding of TCF/LEF:CTNNB1 to target gene promoters,8
1068,0.25821763046582413,Branched-chain amino acid catabolism,19
1761,0.2581984266366052,HDL clearance,5
1488,0.25817485973895066,Axonal growth inhibition (RHOA activation),9
1281,0.2581152731775474,Phospholipase C-mediated cascade; FGFR3,13
1076,0.2580090712706776,Biosynthesis of specialized proresolving mediators (SPMs),19
194,0.25800882146762083,Resolution of Sister Chromatid Cohesion,125
47,0.2578986301969575,Intracellular signaling by second messengers,351
19,0.2577194692576287,Transport of small molecules,740
1014,0.25769223018132353,Blood group systems biosynthesis,21
74,0.2574880268067572,SLC-mediated transmembrane transport,250
612,0.25742643588378583,Signaling by FGFR2 in disease,46
299,0.25740288552779295,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,95
1045,0.25710102090655695,Ras activation upon Ca2+ influx through NMDA receptor,20
1332,0.25708655250810436,FGFR3 mutant receptor activation,12
1315,0.25708655250810436,Signaling by activated point mutants of FGFR3,12
2097,0.25707085551055797,"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",1
1,0.25681039446365955,Signal Transduction,3328
1609,0.2566546260248688,2-LTR circle formation,7
1437,0.25649546279776486,Neurotoxicity of clostridium toxins,10
582,0.25644439463376695,Myogenesis,51
113,0.2564377271081809,Beta-catenin independent WNT signaling,184
270,0.2563242527227054,Peptide hormone metabolism,100
775,0.2561433829231114,Regulation of MECP2 expression and activity,33
776,0.25609394420146897,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,33
2026,0.2559928197124541,Degradation of GABA,2
1826,0.2558981430006227,Threonine catabolism,4
1197,0.25589247167832757,Metabolism of nitric oxide: eNOS activation and regulation,15
271,0.25586124017967193,Toll Like Receptor 9 (TLR9) Cascade,100
1241,0.2558025148470343,AMPK inhibits chREBP transcriptional activation activity,14
805,0.2557775438648924,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",31
798,0.2557775438648924,Trafficking of AMPA receptors,31
1952,0.25561504214534153,Defective GGT1 causes Glutathionuria (GLUTH),2
1649,0.2555378510576858,Transport and synthesis of PAPS,6
1419,0.25528821435888094,Role of second messengers in netrin-1 signaling,10
294,0.25509612903541584,MyD88 dependent cascade initiated on endosome,96
296,0.25509612903541584,Toll Like Receptor 7/8 (TLR7/8) Cascade,96
484,0.25504802665136783,Netrin-1 signaling,61
2080,0.2548708154922023,Defective MPDU1 causes MPDU1-CDG (CDG-1f),1
103,0.2548441148968643,Metabolism of vitamins and cofactors,197
311,0.25468411161361904,Signaling by NOTCH1,93
253,0.25466771065891414,p75 NTR receptor-mediated signalling,104
272,0.2541966134780568,SLC transporter disorders,100
279,0.25396884286040855,Metabolism of nucleotides,99
787,0.25389530682421013,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,32
244,0.2538020666976259,Stimuli-sensing channels,106
111,0.25367992662189837,Transport to the Golgi and subsequent modification,185
696,0.25367975544279614,HSF1-dependent transactivation,38
1243,0.25343949442785485,Metallothioneins bind metals,14
1666,0.2532855027245146,SMAD2/3 Phosphorylation Motif Mutants in Cancer,6
1675,0.2532855027245146,TGFBR1 KD Mutants in Cancer,6
1044,0.2531423093716154,Prolonged ERK activation events,20
1269,0.25312751619046225,IRF3-mediated induction of type I IFN,13
1041,0.25295731949135164,MECP2 regulates neuronal receptors and channels,20
362,0.2528465337642125,Centrosome maturation,81
365,0.2528465337642125,Recruitment of mitotic centrosome proteins and complexes,81
920,0.25263459703636143,Sema4D induced cell migration and growth-cone collapse,25
1357,0.2524814938512503,Pregnenolone biosynthesis,12
13,0.2523637548960408,Disease,1158
91,0.25231551192862833,Biological oxidations,220
988,0.252115498399488,ADP signalling through P2Y purinoceptor 12,22
1385,0.25210624310326585,Caspase activation via Dependence Receptors in the absence of ligand,11
1170,0.2520286658948974,STING mediated induction of host immune responses,16
975,0.25196780995814044,SUMOylation of transcription factors,22
1467,0.2518827461041069,E2F-enabled inhibition of pre-replication complex formation,9
702,0.2517902901007556,Prostacyclin signalling through prostacyclin receptor,38
724,0.2514107171375873,SHC1 events in ERBB2 signaling,36
768,0.25134502138212245,Glucagon signaling in metabolic regulation,33
756,0.2512421284225039,Signaling by WNT in cancer,34
1680,0.25120540251625373,TNFR1-mediated ceramide production,6
861,0.2510781903224186,Keratan sulfate biosynthesis,28
831,0.2510445484488675,Sema4D in semaphorin signaling,29
281,0.2508947245913455,Circadian Clock,99
1561,0.25076070514779936,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,8
1461,0.25057579378545425,HDR through MMEJ (alt-NHEJ),10
171,0.2505249043819148,Signaling by TGF-beta family members,136
574,0.25047588281994426,Defensins,52
1234,0.2503182773157669,Peptide hormone biosynthesis,14
1376,0.2503147117624454,Sodium/Calcium exchangers,11
1614,0.2502117033410766,Loss of Function of SMAD2/3 in Cancer,7
992,0.2501824817004756,Prolactin receptor signaling,21
709,0.25010876403941334,G1/S-Specific Transcription,37
606,0.24994735929207118,"Adrenaline,noradrenaline inhibits insulin secretion",47
1430,0.2490103429960319,p75NTR regulates axonogenesis,10
4,0.24895925059182114,Metabolism,2251
308,0.24875819216205455,Recruitment of NuMA to mitotic centrosomes,94
666,0.2487457102253525,Activated NOTCH1 Transmits Signal to the Nucleus,41
22,0.2487268648892586,Axon guidance,700
891,0.2486807059071749,RUNX3 regulates NOTCH signaling,26
1693,0.2486364415787113,RUNX1 regulates expression of components of tight junctions,5
471,0.2485527030231811,Regulation of cholesterol biosynthesis by SREBP (SREBF),63
699,0.24836388896825304,Plasma lipoprotein clearance,38
1270,0.2481783239240207,Keratan sulfate degradation,13
633,0.2481752427336345,Intra-Golgi traffic,44
1771,0.24801317210614665,Cholesterol biosynthesis via desmosterol,4
1796,0.24801317210614665,Cholesterol biosynthesis via lathosterol,4
1092,0.24796271131249303,Regulation of RUNX1 Expression and Activity,18
802,0.24795388151329625,Inwardly rectifying K+ channels,31
949,0.2479111264470923,IKK complex recruitment mediated by RIP1,23
276,0.2476674550950699,COPI-dependent Golgi-to-ER retrograde traffic,99
346,0.24732283010136594,Signaling by Insulin receptor,85
58,0.24729538340865045,PIP3 activates AKT signaling,304
54,0.24693830662502458,Metabolism of carbohydrates,311
1954,0.24684310573520635,Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),2
1150,0.24650796766486904,Glycogen synthesis,16
287,0.24639017840346225,Anchoring of the basal body to the plasma membrane,97
794,0.24629479893941458,Pyruvate metabolism,31
1685,0.2462295526209042,Vitamins,6
183,0.24616503288479147,PPARA activates gene expression,132
336,0.24611516418010917,Regulation of PLK1 Activity at G2/M Transition,87
1113,0.24598393106367814,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",17
264,0.24588166385937393,MyD88-independent TLR4 cascade ,102
267,0.24588166385937393,TRIF(TICAM1)-mediated TLR4 signaling ,102
866,0.2457772419855717,Adenylate cyclase inhibitory pathway,27
175,0.24568755562193753,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),134
790,0.24554238708993864,"BMAL1:CLOCK,NPAS2 activates circadian gene expression",32
252,0.24554032863582215,Diseases of metabolism,104
1030,0.24547461162623585,LDL clearance,20
899,0.2453806173117633,Deadenylation of mRNA,25
85,0.24487276319398105,ESR-mediated signaling,227
360,0.2448361819380708,Antiviral mechanism by IFN-stimulated genes,82
1973,0.24482799558554158,Entry of Influenza Virion into Host Cell via Endocytosis,2
516,0.24457747081804704,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,58
962,0.24454786389002872,FRS-mediated FGFR1 signaling,23
1359,0.24454280487585,rRNA processing in the mitochondrion,12
1903,0.24448468552369398,5-Phosphoribose 1-diphosphate biosynthesis,3
1480,0.24447201902246946,Integration of provirus,9
743,0.24435384407420854,Signaling by NTRK2 (TRKB),35
382,0.24422372350396135,SUMOylation of DNA damage response and repair proteins,77
957,0.24418589403548602,E2F mediated regulation of DNA replication,23
280,0.2441493844565576,Potassium Channels,99
1524,0.24376854390959024,RUNX3 regulates WNT signaling,8
523,0.24360046079407685,NOTCH1 Intracellular Domain Regulates Transcription,58
583,0.24316636383718102,Signalling to ERKs,51
1339,0.2429918099661891,Release of Hh-Np from the secreting cell,12
178,0.2428952879831695,Transcriptional regulation of white adipocyte differentiation,133
396,0.24280018763498717,ISG15 antiviral mechanism,74
156,0.24276739237570094,RHO GTPases Activate Formins,146
1945,0.2427462544160307,Influenza Virus Induced Apoptosis,2
1788,0.242701985302334,Transcription from mitochondrial promoters,4
2230,0.2426746810821826,Defective CYP19A1 causes Aromatase excess syndrome (AEXS),1
1424,0.24244194494212623,"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",10
812,0.2423035694971193,Signalling to RAS,31
943,0.242260364502944,BBSome-mediated cargo-targeting to cilium,23
112,0.2422284794764972,Factors involved in megakaryocyte development and platelet production,184
1445,0.2421118497509116,AKT phosphorylates targets in the nucleus,10
391,0.24209730060250895,Transcriptional Regulation by MECP2,75
2197,0.24152963054961674,Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX),1
474,0.24148765830644978,Synthesis of substrates in N-glycan biosythesis,63
1100,0.24135335669724992,Cell-extracellular matrix interactions,18
420,0.24094111152501355,Intraflagellar transport,71
734,0.24090634888035958,Downregulation of SMAD2/3:SMAD4 transcriptional activity,35
1107,0.24067819012766437,Phospholipase C-mediated cascade; FGFR2,18
566,0.24058288596852806,COPI-independent Golgi-to-ER retrograde traffic,52
1005,0.2403909880063064,PI-3K cascade:FGFR1,21
559,0.24018746796249824,Nuclear Receptor transcription pathway,53
784,0.23984685215609022,NEP/NS2 Interacts with the Cellular Export Machinery,32
69,0.2395683328959863,Neurotransmitter receptors and postsynaptic signal transmission,265
1719,0.2394498579196313,Fructose catabolism,5
1726,0.2394225340221016,Galactose catabolism,5
1235,0.23923791770565828,Inhibition of replication initiation of damaged DNA by RB1/E2F1,14
269,0.23922272066708464,Cellular response to heat stress,101
908,0.23906566185332764,Repression of WNT target genes,25
678,0.23904215544647336,Negative regulation of MAPK pathway,40
197,0.23903132225565324,Metabolism of water-soluble vitamins and cofactors,123
964,0.238927998147372,Common Pathway of Fibrin Clot Formation,22
1130,0.23892632359335858,Activated point mutants of FGFR2,17
99,0.23864273492574067,Intra-Golgi and retrograde Golgi-to-ER traffic,203
493,0.23857199494733583,Carboxyterminal post-translational modifications of tubulin,60
330,0.23855963262162488,Toll Like Receptor 5 (TLR5) Cascade,89
329,0.23855963262162488,MyD88 cascade initiated on plasma membrane,89
328,0.23855963262162488,Toll Like Receptor 10 (TLR10) Cascade,89
1913,0.23849480515017085,RHO GTPases regulate CFTR trafficking,3
1539,0.2383498824067293,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,8
529,0.23812261991143627,Golgi Associated Vesicle Biogenesis,56
443,0.23799048081499166,Signaling by ERBB4,68
1714,0.23797622451617761,Formation of xylulose-5-phosphate,5
760,0.2379515459004341,Vpr-mediated nuclear import of PICs,34
50,0.2377959152943656,Transmission across Chemical Synapses,335
1291,0.23777206484549637,Erythrocytes take up carbon dioxide and release oxygen,13
1294,0.23777206484549637,O2/CO2 exchange in erythrocytes,13
757,0.2376105326304984,Synthesis of bile acids and bile salts,34
2139,0.2374500520572339,Defective SLC12A3 causes Gitelman syndrome (GS),1
1413,0.23740285032059436,Regulation of PTEN mRNA translation,10
758,0.23722180130194126,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",34
1678,0.2370064387958306,Choline catabolism,6
1336,0.23685995421661044,Physiological factors,12
589,0.23685467767407795,Signaling by FGFR1,50
735,0.23682678671367208,Lysosome Vesicle Biogenesis,35
823,0.23677492367255673,Ephrin signaling,30
809,0.23675506843028407,FGFR1 mutant receptor activation,31
936,0.23674304640870292,Glutamate Neurotransmitter Release Cycle,24
1458,0.23653444188798062,Activation of Ca-permeable Kainate Receptor,10
1457,0.23653444188798062,Ionotropic activity of kainate receptors,10
716,0.2365271344735369,Nuclear Pore Complex (NPC) Disassembly,36
1236,0.2364843596466704,Pervasive developmental disorders,14
1255,0.2364843596466704,Loss of function of MECP2 in Rett syndrome,14
2086,0.23625974404096797,Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD),1
1993,0.23608864808765298,Transport of glycerol from adipocytes to the liver by Aquaporins,2
856,0.23602327583850058,Downregulation of ERBB2 signaling,28
2157,0.23597921805072408,COX reactions,1
470,0.23567461570239778,Transcriptional activation of mitochondrial biogenesis,63
1008,0.23560405923767147,FOXO-mediated transcription of cell death genes,21
783,0.23558380391601735,Transport of Ribonucleoproteins into the Host Nucleus,32
1046,0.23550372667616726,Receptor-type tyrosine-protein phosphatases,20
411,0.23547210872036667,trans-Golgi Network Vesicle Budding,72
202,0.23533951996316718,Rab regulation of trafficking,122
1323,0.2353181136235024,Hyaluronan uptake and degradation,12
177,0.23513473443869143,Golgi-to-ER retrograde transport,133
1474,0.2348659117784978,Serine biosynthesis,9
646,0.23477261578231637,Host Interactions with Influenza Factors,43
1342,0.23464552131165228,GP1b-IX-V activation signalling,12
1672,0.2345319862753751,Assembly of the ORC complex at the origin of replication,6
867,0.23452077935998106,Phase 2 - plateau phase,27
1133,0.23451562317008565,Biosynthesis of DHA-derived SPMs,17
954,0.2345113002196642,DCC mediated attractive signaling,23
1200,0.23444407951992685,Frs2-mediated activation,15
30,0.23439773604506617,Neuronal System,498
668,0.23438365780018397,NS1 Mediated Effects on Host Pathways,41
737,0.2343718689009651,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",35
578,0.2343256962554765,Neurotransmitter release cycle,51
835,0.23425258877847605,Uptake and actions of bacterial toxins,29
681,0.2342425756162016,Presynaptic phase of homologous DNA pairing and strand exchange,39
7,0.23424106830193717,Post-translational protein modification,1512
1807,0.2341400805710916,Scavenging by Class H Receptors,4
654,0.23366697677886367,Homologous DNA Pairing and Strand Exchange,42
2200,0.23363795414877936,"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)",1
986,0.23357542724577476,Pre-NOTCH Processing in Golgi,22
338,0.23357184835799083,DDX58/IFIH1-mediated induction of interferon-alpha/beta,87
773,0.23340275902447283,Export of Viral Ribonucleoproteins from Nucleus,33
1222,0.23331166397583666,TRAF3-dependent IRF activation pathway,14
46,0.23310524301076485,Transcriptional Regulation by TP53,364
705,0.23276260221478065,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,37
567,0.23266703276606068,GABA B receptor activation,52
564,0.23266703276606068,Activation of GABAB receptors,52
431,0.2326574135293212,Interactions of Rev with host cellular proteins,69
250,0.23261538078117217,PCP/CE pathway,105
1006,0.2325239595814333,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,21
2154,0.232426798130347,Defective GALK1 can cause Galactosemia II (GALCT2),1
1180,0.23218270332749344,Signaling by NOTCH1 HD Domain Mutants in Cancer,15
1203,0.23218270332749344,Constitutive Signaling by NOTCH1 HD Domain Mutants,15
137,0.23196206475399386,Host Interactions of HIV factors,162
635,0.23193621260598532,Interaction between L1 and Ankyrins,44
79,0.2318095570230596,SUMOylation,238
754,0.23175949051427144,MAPK targets/ Nuclear events mediated by MAP kinases,34
847,0.23174079276520984,Attenuation phase,28
83,0.2317273959077868,SUMO E3 ligases SUMOylate target proteins,230
284,0.2317148953480198,Toll Like Receptor 3 (TLR3) Cascade,98
1343,0.23168316079739668,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,12
1840,0.2315627889469607,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,3
1849,0.2315627889469607,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,3
1895,0.2315627889469607,Diseases of Cellular Senescence,3
1848,0.2315627889469607,Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,3
1841,0.2315627889469607,Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,3
144,0.23141829920878962,Metabolism of steroids,158
1456,0.23140635319106387,IRAK2 mediated activation of TAK1 complex,10
1129,0.23128481312825042,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,17
1274,0.231103442097567,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",13
710,0.23105336858528924,Regulation of TP53 Expression and Degradation,37
357,0.2310501288475932,Recycling pathway of L1,82
777,0.23100211769856557,Regulation of TNFR1 signaling,33
1123,0.23097538346686677,Vitamin B5 (pantothenate) metabolism,17
1582,0.23093432762136337,HuR (ELAVL1) binds and stabilizes mRNA,8
591,0.23081426893174378,Activation of gene expression by SREBF (SREBP),49
952,0.23072572847422645,Class I peroxisomal membrane protein import,23
1956,0.23066982127608268,Defective MMAA causes methylmalonic aciduria type cblA,2
1974,0.23066982127608268,Defective MUT causes methylmalonic aciduria mut type,2
652,0.23062788735167147,Deactivation of the beta-catenin transactivating complex,42
1590,0.23044981999875175,Wax and plasmalogen biosynthesis,7
736,0.23035353135661524,PERK regulates gene expression,35
717,0.23025833355610428,Nuclear import of Rev protein,36
1823,0.23021549857642384,"Activation, myristolyation of BID and translocation to mitochondria",4
998,0.23017721292855767,SHC-mediated cascade:FGFR1,21
816,0.2300888883464816,TNFR1-induced NFkappaB signaling pathway,30
2005,0.2300848669187316,Defective CD320 causes methylmalonic aciduria,2
305,0.22998920820731092,Amplification of signal from the kinetochores,94
304,0.22998920820731092,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,94
748,0.2298315277870077,Transcriptional Regulation by E2F6,34
57,0.22980240113418046,Asparagine N-linked glycosylation,305
759,0.2295716081095399,Keratan sulfate/keratin metabolism,34
437,0.22954377988481656,COPII-mediated vesicle transport,68
767,0.2295100282509451,Resolution of D-loop Structures through Holliday Junction Intermediates,33
2054,0.22929083651505072,MPS IX - Natowicz syndrome,1
285,0.22906660631047118,Regulation of PTEN gene transcription,97
786,0.22904100297381524,Regulation of Glucokinase by Glucokinase Regulatory Protein,32
793,0.22904100297381524,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),32
745,0.22895111846467886,SUMOylation of SUMOylation proteins,35
378,0.2289298014350998,SUMOylation of DNA replication proteins,78
261,0.22873879324746899,Signaling by TGF-beta Receptor Complex,102
1906,0.22870051554126236,Vitamins B6 activation to pyridoxal phosphate,3
610,0.22864222904776169,SUMOylation of RNA binding proteins,47
965,0.2286041614134315,InlB-mediated entry of Listeria monocytogenes into host cell,22
929,0.22823411162206408,NOTCH2 Activation and Transmission of Signal to the Nucleus,24
286,0.2282199809959719,G2/M DNA damage checkpoint,97
356,0.2281504989287792,Regulation of HSF1-mediated heat shock response,82
884,0.22775402433257888,Constitutive Signaling by AKT1 E17K in Cancer,26
747,0.22773899550700638,Transport of the SLBP independent Mature mRNA,35
2056,0.22747886201155382,MPS VI - Maroteaux-Lamy syndrome,1
1250,0.22730189905434026,Defects in cobalamin (B12) metabolism,14
1384,0.2272933874234102,Phenylalanine and tyrosine metabolism,11
2038,0.22727838325996777,Defective DHDDS causes retinitis pigmentosa 59,2
1441,0.2271022245307032,Synthesis of pyrophosphates in the cytosol,10
924,0.22705348575317785,ZBP1(DAI) mediated induction of type I IFNs,24
934,0.22703289498915127,FOXO-mediated transcription of cell cycle genes,24
1883,0.22700220919011116,Defective DPM3 causes DPM3-CDG (CDG-1o),3
1886,0.22700220919011116,Defective DPM1 causes DPM1-CDG (CDG-1e),3
1866,0.22700220919011116,Synthesis of dolichyl-phosphate mannose,3
1885,0.22700220919011116,Defective DPM2 causes DPM2-CDG (CDG-1u),3
999,0.22683270920708934,Glycogen breakdown (glycogenolysis),21
147,0.22681979001065,ER to Golgi Anterograde Transport,154
886,0.22679613178994457,Nephrin family interactions,26
997,0.22671976864580037,Synthesis of PIPs at the Golgi membrane,21
2172,0.2267120552688272,Defective ALG11 causes ALG11-CDG (CDG-1p),1
1360,0.22647875141696322,RSK activation,11
755,0.22640606236793923,Resolution of D-Loop Structures,34
742,0.22632063762115187,Rev-mediated nuclear export of HIV RNA,35
708,0.22627552722015698,HDR through Single Strand Annealing (SSA),37
1143,0.22622923145802765,AKT phosphorylates targets in the cytosol,17
694,0.22618598350175384,NOD1/2 Signaling Pathway,38
520,0.22617268271370525,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,58
517,0.22617268271370525,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,58
519,0.22617268271370525,Constitutive Signaling by NOTCH1 PEST Domain Mutants,58
518,0.22617268271370525,Signaling by NOTCH1 in Cancer,58
521,0.22617268271370525,Signaling by NOTCH1 PEST Domain Mutants in Cancer,58
732,0.22574549014019357,Transport of the SLBP Dependant Mature mRNA,36
619,0.2257034061948688,Glycosphingolipid metabolism,45
1214,0.2254241182466836,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,14
877,0.22534249440948267,Downstream signaling of activated FGFR4,27
35,0.2252623536779847,Cellular responses to stress,464
377,0.22514920691900234,"Plasma lipoprotein assembly, remodeling, and clearance",79
8,0.22512375060134546,Generic Transcription Pathway,1421
1839,0.22478916347849076,TRAF3 deficiency - HSE,3
808,0.22478909637690517,Transferrin endocytosis and recycling,31
1793,0.22453159047515162,Transcriptional  activation of  cell cycle inhibitor p21 ,4
1784,0.22453159047515162,Transcriptional activation of p53 responsive genes  ,4
229,0.22414905140853228,Mitotic Spindle Checkpoint,110
34,0.22403327092309688,Signaling by WNT,466
1062,0.22400098099538904,Metabolism of cofactors,19
711,0.22400006409894882,Interactions of Vpr with host cellular proteins,37
375,0.2239234343197953,Neurexins and neuroligins,79
1060,0.22354687216645108,"GABA synthesis, release, reuptake and degradation",19
1615,0.2234818244622679,Fructose metabolism,7
740,0.22339610064572643,Nuclear signaling by ERBB4,35
719,0.22334637581688707,Downregulation of TGF-beta receptor signaling,36
292,0.22319661891488282,Downstream signaling events of B Cell Receptor (BCR),96
1880,0.22316794979725463,Defective AMN causes hereditary megaloblastic anemia 1,3
1892,0.22316794979725463,Defective CUBN causes hereditary megaloblastic anemia 1,3
1987,0.2231093320689969,Synthesis of dolichyl-phosphate-glucose,2
1555,0.2229949923119101,Signaling by TGF-beta Receptor Complex in Cancer,8
1350,0.22289002287539394,DSCAM interactions,12
374,0.2228794413500959,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",79
142,0.22245040041338354,Antigen processing-Cross presentation,159
6,0.22239694059900078,RNA Polymerase II Transcription,1623
1204,0.2222264376567073,Glycogen storage diseases,15
275,0.22215169208625557,Unfolded Protein Response (UPR),99
101,0.22204169200755802,Mitotic Metaphase and Anaphase,201
25,0.22198007491886446,"Cell Cycle, Mitotic",598
1612,0.22174157592211888,Loss of Function of TGFBR1 in Cancer,7
658,0.221646303697224,"Unblocking of NMDA receptors, glutamate binding and activation",41
16,0.22159803527304736,Cell Cycle,792
845,0.22158589962789454,Notch-HLH transcription pathway,28
1725,0.22135035012378204,G2/M DNA replication checkpoint,5
650,0.22129492352238844,Beta defensins,42
919,0.22120118048594928,DARPP-32 events,25
123,0.22117678021724094,Disorders of transmembrane transporters,177
5,0.22114231582769794,Gene expression (Transcription),1827
102,0.22113834856898876,Mitotic Anaphase,200
1455,0.22112290292743153,ChREBP activates metabolic gene expression,10
45,0.22098431571788865,Metabolism of amino acids and derivatives,382
848,0.22097567854644276,Nuclear Events (kinase and transcription factor activation),28
232,0.22086091082323647,Transcriptional regulation by RUNX3,110
1926,0.22056668713882718,PLC-gamma1 signalling,3
1121,0.2205384707909039,Metabolism of folate and pterines,17
725,0.22047978009244087,FGFR2 mutant receptor activation,36
1665,0.22034977259134636,RUNX1 regulates estrogen receptor mediated transcription,6
87,0.22028684151026806,Cilium Assembly,226
1594,0.22024203085614477,Cation-coupled Chloride cotransporters,7
837,0.22015291500263698,Negative regulation of FGFR3 signaling,29
1105,0.2200399997276924,Response to metal ions,18
1585,0.21974594383310966,Vitamin B2 (riboflavin) metabolism,7
657,0.21968068216131315,Transport of Mature mRNA Derived from an Intronless Transcript,42
721,0.219555968635597,Regulation of TP53 Degradation,36
228,0.21953186941136654,Signaling by NTRK1 (TRKA),110
11,0.21951437781558755,Signaling by GPCR,1256
824,0.2193441147727007,RAF activation,30
1337,0.21932275464027462,VLDLR internalisation and degradation,12
1679,0.2192485368183458,Pre-NOTCH Processing in the Endoplasmic Reticulum,6
51,0.21920315817261257,Organelle biogenesis and maintenance,329
1751,0.21899643163037177,Defective LFNG causes SCDO3,5
26,0.218882712299198,Cellular responses to external stimuli,568
779,0.21878076615882108,Glycogen metabolism,33
1340,0.21877731134006714,Caspase-mediated cleavage of cytoskeletal proteins,12
640,0.21860724621943511,Bile acid and bile salt metabolism,43
917,0.218508006808989,Activation of G protein gated Potassium channels,25
905,0.218508006808989,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,25
921,0.218508006808989,G protein gated Potassium channels,25
1933,0.21844465839822563,Virus Assembly and Release,2
2008,0.21844465839822563,Assembly of Viral Components at the Budding Site,2
1520,0.2183875305395085,MECP2 regulates transcription of neuronal ligands,8
2030,0.21821592460280242,Pyrophosphate hydrolysis,2
645,0.2181991035599278,Transport of Mature mRNAs Derived from Intronless Transcripts,43
1616,0.21818899514038398,Digestion of dietary lipid,7
1499,0.21808733373875108,Erythrocytes take up oxygen and release carbon dioxide,9
549,0.2178477621079747,Complex I biogenesis,55
248,0.2177927985798793,Chaperonin-mediated protein folding,105
814,0.21770414702774596,Cyclin A/B1/B2 associated events during G2/M transition,30
129,0.21768898977899967,Mitotic G1-G1/S phases,173
1435,0.21746234739562995,Activation of the AP-1 family of transcription factors,10
3,0.2174617089227585,Metabolism of proteins,2347
648,0.21741180038983524,TGF-beta receptor signaling activates SMADs,43
163,0.21707298640459846,Signaling by NTRKs,143
105,0.2170158235525361,Separation of Sister Chromatids,189
627,0.2170074977271111,Phase 0 - rapid depolarisation,44
257,0.21682536754824228,Mitochondrial biogenesis,103
1502,0.2166547751801261,Glucocorticoid biosynthesis,9
753,0.21650421782547988,Negative regulation of FGFR2 signaling,34
1367,0.21641645279801827,CDC6 association with the ORC:origin complex,11
1692,0.21613703962453354,Arachidonate production from DAG,5
317,0.21600513331268648,Interferon alpha/beta signaling,91
40,0.2157442043165042,M Phase,414
1992,0.21548559335541154,Interactions of Tat with host cellular proteins,2
691,0.2154772382628122,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,38
259,0.21518814336588973,ABC-family proteins mediated transport,103
1152,0.21509294115866837,Polo-like kinase mediated events,16
1293,0.21507572171467113,Downregulation of ERBB2:ERBB3 signaling,13
686,0.2149813503858038,SUMOylation of ubiquitinylation proteins,39
227,0.21465774387762235,Protein folding,110
38,0.21457396123490394,Class I MHC mediated antigen processing & presentation,436
1470,0.2144949592705192,Beta-oxidation of pristanoyl-CoA,9
1791,0.21447227641612387,Axonal growth stimulation,4
833,0.2144334039168543,Synthesis of PC,29
547,0.21426155874702518,Cross-presentation of soluble exogenous antigens (endosomes),55
1213,0.21411523314888445,"Synthesis of IP2, IP, and Ins in the cytosol",14
1715,0.21407178633571058,Free fatty acid receptors,5
12,0.21386374490170748,GPCR downstream signalling,1192
1279,0.21380180180288197,RHO GTPases Activate Rhotekin and Rhophilins,13
1289,0.21372924067778726,PI3K/AKT activation,13
1209,0.21360232664839943,ERBB2 Regulates Cell Motility,15
100,0.21351696013306745,G2/M Transition,202
1351,0.2133033199229234,ATF6 (ATF6-alpha) activates chaperones,12
1072,0.2132276019283671,p38MAPK events,19
268,0.21318741404079639,COPI-mediated anterograde transport,101
358,0.2131788079329043,GABA receptor activation,82
1558,0.21289525663181225,Estrogen-stimulated signaling through PRKCZ,8
97,0.21274641612180115,Mitotic G2-G2/M phases,204
2067,0.2124173787823664,Latent infection - Other responses of Mtb to phagocytosis,1
2063,0.2124173787823664,Mtb iron assimilation by chelation,1
637,0.21214375577991346,Voltage gated Potassium channels,43
2127,0.21200806278733095,"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",1
1762,0.21196103522734036,NOSTRIN mediated eNOS trafficking,5
1361,0.21191222376930624,Formation of annular gap junctions,11
217,0.2117464836784448,Protein-protein interactions at synapses,115
1448,0.21169744070752836,Chylomicron remodeling,10
64,0.21160218696170055,Signaling by NOTCH,291
1822,0.2115708102075215,Glycine degradation,4
882,0.21147637068033476,ATF4 activates genes in response to endoplasmic reticulum  stress,26
239,0.21130615493238725,Phase II - Conjugation of compounds,108
1205,0.21122322184652612,T41 mutants of beta-catenin aren't phosphorylated,15
1202,0.21122322184652612,S45 mutants of beta-catenin aren't phosphorylated,15
1189,0.21122322184652612,S37 mutants of beta-catenin aren't phosphorylated,15
1196,0.21122322184652612,Misspliced GSK3beta mutants stabilize beta-catenin,15
1186,0.21122322184652612,S33 mutants of beta-catenin aren't phosphorylated,15
1181,0.21122322184652612,phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,15
1852,0.21118783205690442,ARL13B-mediated ciliary trafficking of INPP5E,3
1986,0.21086912952755058,Mitotic Metaphase/Anaphase Transition,2
1620,0.21059684205793197,DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,7
1416,0.2104290186266403,Signal attenuation,10
541,0.21024181410297102,Pyruvate metabolism and Citric Acid (TCA) cycle,55
65,0.21019117319506783,HIV Infection,290
59,0.20984404437943133,Transcriptional regulation by RUNX1,302
1949,0.20980881277396543,NOSIP mediated eNOS trafficking,2
406,0.20955483335352137,Glycolysis,73
2053,0.2092933526331966,ALKBH2 mediated reversal of alkylation damage,1
141,0.20922223927886105,Regulation of TP53 Activity,160
2141,0.20892773464412737,Defective SLC17A5 causes Salla disease (SD) and ISSD,1
629,0.20889106211764485,"Transport of vitamins, nucleosides, and related molecules",44
1566,0.208513251733268,HDL assembly,8
1379,0.20848909343720215,Mucopolysaccharidoses,11
1366,0.2084605356519358,"TICAM1,TRAF6-dependent induction of TAK1 complex",11
63,0.20826320694411804,Cell Cycle Checkpoints,293
634,0.2080253832527901,Viral Messenger RNA Synthesis,44
1580,0.2076538394121838,The retinoid cycle in cones (daylight vision),8
313,0.20762342117307578,Glucose metabolism,92
1673,0.20753331051527527,Mineralocorticoid biosynthesis,6
2124,0.20749819584722992,Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),1
1103,0.206890402879781,Activation of the phototransduction cascade,18
1171,0.20684978344269153,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,16
289,0.20667595565056227,RHO GTPases activate PKNs,97
1158,0.20663302406716785,Degradation of cysteine and homocysteine,16
127,0.2066246110822808,S Phase,174
258,0.20565028594616283,CLEC7A (Dectin-1) signaling,103
512,0.2054639472373362,Cargo trafficking to the periciliary membrane,59
273,0.20520607012164796,Respiratory electron transport,100
1613,0.2051611644259343,Loss of MECP2 binding ability to the NCoR/SMRT complex,7
154,0.2050030702059334,G1/S Transition,147
1354,0.2048851820599399,NOTCH4 Activation and Transmission of Signal to the Nucleus,12
452,0.20469600068807692,Cytosolic sensors of pathogen-associated DNA ,66
1842,0.20451849155232146,Toxicity of botulinum toxin type B (BoNT/B),3
894,0.20435890992996592,Insulin receptor recycling,26
985,0.20435859271407206,FRS-mediated FGFR4 signaling,22
983,0.20430224923641294,Defects in vitamin and cofactor metabolism,22
744,0.2041142617308997,Plasma lipoprotein remodeling,35
1552,0.2040998503762253,Synthesis of Ketone Bodies,8
1075,0.2039749780126724,Signaling by FGFR2 IIIa TM,19
467,0.20396613331070224,Deadenylation-dependent mRNA decay,64
314,0.2038515913292179,Regulation of TP53 Activity through Phosphorylation,92
246,0.20359896789940135,Transcriptional regulation of granulopoiesis,105
707,0.2035846931808835,SUMOylation of intracellular receptors,37
660,0.20352279156063194,Signaling by FGFR4,41
121,0.20345038463818044,The citric acid (TCA) cycle and respiratory electron transport,178
1063,0.20337725979077287,Assembly of active LPL and LIPC lipase complexes,19
1260,0.20337467863793757,AMER1 mutants destabilize the destruction complex,14
1212,0.20337467863793757,APC truncation mutants have impaired AXIN binding,14
1256,0.20337467863793757,truncated APC mutants destabilize the destruction complex,14
1229,0.20337467863793757,"AXIN mutants destabilize the destruction complex, activating WNT signaling",14
1252,0.20337467863793757,Truncations of AMER1 destabilize the destruction complex,14
1230,0.20337467863793757,AXIN missense mutants destabilize the destruction complex,14
945,0.2033124587351644,Dopamine Neurotransmitter Release Cycle,23
151,0.203105080561304,Estrogen-dependent gene expression,150
1703,0.2030835451579868,Expression and Processing of Neurotrophins,5
1748,0.2030835451579868,NGF processing,5
2051,0.20266358146866098,MPS IIIC - Sanfilippo syndrome C,1
1853,0.20263795806937945,Toxicity of botulinum toxin type G (BoNT/G),3
2044,0.20259691455677234,WNT ligand secretion is abrogated by the PORCN inhibitor LGK974,1
1301,0.2024684558877295,TNFR1-induced proapoptotic signaling,13
1744,0.2024305980049328,NGF-independant TRKA activation,5
585,0.20201927073913756,Retrograde transport at the Trans-Golgi-Network,50
1682,0.20176008941600074,SUMO is proteolytically processed,6
1667,0.20167784309340095,Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,6
1172,0.20157060485671877,FGFR1 ligand binding and activation,16
339,0.20144648553340705,Cellular response to hypoxia,87
655,0.20142956812143634,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,42
1465,0.2013263752108478,Downregulation of ERBB4 signaling,9
1516,0.20124809408302846,Vitamin C (ascorbate) metabolism,8
148,0.20102596812526072,RNA polymerase II transcribes snRNA genes,154
761,0.2010185339632395,Diseases of carbohydrate metabolism,34
1311,0.2009772614327973,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,12
1303,0.20046976133302494,Apoptosis induced DNA fragmentation,13
888,0.20045452030980201,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),26
200,0.2004135665848189,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",123
580,0.20036056067597555,IRE1alpha activates chaperones,51
925,0.20027770675645176,RHO GTPases activate CIT,24
617,0.19997384346830818,SUMOylation of transcription cofactors,45
594,0.19956269425082585,Association of TriC/CCT with target proteins during biosynthesis,48
914,0.19933643005061086,ERK/MAPK targets,25
749,0.19920204937737043,NOTCH3 Activation and Transmission of Signal to the Nucleus,34
1344,0.19915269959598592,Glycoprotein hormones,12
830,0.1988898844169003,Interconversion of nucleotide di- and triphosphates,29
551,0.1988227364776652,Metabolism of non-coding RNA,54
550,0.1988227364776652,snRNP Assembly,54
598,0.19872845039706707,DNA Damage Bypass,48
353,0.19865156788608196,Cyclin E associated events during G1/S transition ,83
852,0.19861104102590685,RUNX2 regulates osteoblast differentiation,28
2073,0.19853406667349427,Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD),1
2171,0.1984831576971787,Defective ALG1 causes ALG1-CDG (CDG-1k),1
1659,0.1982650213401065,NADE modulates death signalling,6
211,0.1981576752703711,Autophagy,118
388,0.19786685961254818,Interleukin-17 signaling,76
836,0.19783776167156583,PIWI-interacting RNA (piRNA) biogenesis,29
765,0.19777678591161763,Glucagon-type ligand receptors,33
1741,0.19777604282321842,Beta oxidation of butanoyl-CoA to acetyl-CoA,5
774,0.19771289644505213,Negative regulation of FGFR1 signaling,33
859,0.19762432059550764,Budding and maturation of HIV virion,28
405,0.19732265497679247,SUMOylation of chromatin organization proteins,73
1464,0.1972717879949908,Regulation of PTEN localization,9
1396,0.19720106863617518,Uptake and function of anthrax toxins,11
898,0.19716393841977914,Cholesterol biosynthesis,25
37,0.19709810182806115,Infectious disease,445
746,0.19708207579332315,RUNX2 regulates bone development,35
1978,0.19698016246447272,mRNA Editing: A to I Conversion,2
2042,0.19698016246447272,Formation of editosomes by ADAR proteins,2
1990,0.19698016246447272,C6 deamination of adenosine,2
806,0.1969506121510135,Endosomal Sorting Complex Required For Transport (ESCRT),31
1317,0.1968754289263621,Gap junction degradation,12
1287,0.19666896854970461,FGFRL1 modulation of FGFR1 signaling,13
503,0.1966350325139149,tRNA processing in the nucleus,59
126,0.19652410764507283,HIV Life Cycle,175
441,0.19630802491768296,MAP kinase activation,68
902,0.1962508042915438,Long-term potentiation,25
1537,0.1962403528175056,Activation of TRKA receptors,8
1758,0.19623185710070573,IRS activation,5
1039,0.1961361152951413,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,20
1025,0.1961361152951413,Inactivation of APC/C via direct inhibition of the APC/C complex,20
1371,0.19611601450809157,Regulated proteolysis of p75NTR,11
1122,0.1960550327205156,RIP-mediated NFkB activation via ZBP1,17
841,0.19601542723329235,VxPx cargo-targeting to cilium,29
1601,0.19600436648421457,"Activation of NIMA Kinases NEK9, NEK6, NEK7",7
1028,0.19597494591856793,PI-3K cascade:FGFR4,20
834,0.1958177492475765,Digestion and absorption,29
1835,0.19562007010280894,TRKA activation by NGF,4
130,0.19556660805786275,G2/M Checkpoints,170
344,0.19526199374668607,Cyclin A:Cdk2-associated events at S phase entry,85
1073,0.19513000560636504,"TICAM1, RIP1-mediated IKK complex recruitment ",19
714,0.19503634493905553,Activation of ATR in response to replication stress,37
1139,0.19483489031074774,Beta-catenin phosphorylation cascade,17
2021,0.19481968243805917,Agmatine biosynthesis,2
218,0.19459283576028433,tRNA processing,115
1082,0.1942336469621734,Diseases associated with glycosylation precursor biosynthesis,18
1479,0.1942011109569796,Myoclonic epilepsy of Lafora,9
125,0.194172537200568,PTEN Regulation,176
1064,0.19407938511487993,Processing of Intronless Pre-mRNAs,19
1077,0.19403956569001474,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,19
1638,0.1937044092727961,TLR3-mediated TICAM1-dependent programmed cell death,6
1232,0.19367072750652095,Import of palmitoyl-CoA into the mitochondrial matrix,14
1654,0.193459591575647,p75NTR negatively regulates cell cycle via SC1,6
938,0.19342477664597327,Mismatch Repair,24
1581,0.19337374839380142,DNA replication initiation,8
1546,0.19337374839380142,Telomere C-strand synthesis initiation,8
312,0.19321982703492174,MAPK6/MAPK4 signaling,93
723,0.19292822800323506,Oncogene Induced Senescence,36
2077,0.19291275780603345,Defective MMAB causes methylmalonic aciduria type cblB,1
766,0.19285799898229192,Activation of the pre-replicative complex,33
1228,0.19282538479161665,Polymerase switching,14
1264,0.19282538479161665,Leading Strand Synthesis,14
1226,0.19282538479161665,Polymerase switching on the C-strand of the telomere,14
1004,0.19267184502261542,Cellular hexose transport,21
444,0.19266662505344737,HDR through Homologous Recombination (HRR),67
1607,0.1925154456596583,Attachment of GPI anchor to uPAR,7
146,0.19246347596094998,Mitotic Prophase,154
53,0.19243445785754368,TCF dependent signaling in response to WNT,320
944,0.1918721551737937,mRNA decay by 5' to 3' exoribonuclease,23
667,0.19186638724738936,RNA Polymerase III Abortive And Retractive Initiation,41
651,0.1916783818282595,Amine ligand-binding receptors,42
1507,0.19135195922691142,tRNA modification in the mitochondrion,9
1443,0.19131971277895815,ATF6 (ATF6-alpha) activates chaperone genes,10
1109,0.19114521331452353,SUMOylation of DNA methylation proteins,18
55,0.19102481748594838,Antigen processing: Ubiquitination & Proteasome degradation,308
1959,0.19092826584025063,NEIL3-mediated resolution of ICLs,2
2223,0.19092826584025063,Defective Base Excision Repair Associated with NEIL3,1
256,0.19061289362547118,Interleukin-1 signaling,103
1442,0.19058211837027347,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,10
1528,0.19029467743201214,TYSND1 cleaves peroxisomal proteins,8
98,0.1902145863318473,Cellular Senescence,203
789,0.19018370139067098,RNA Polymerase I Transcription Termination,32
1918,0.1901729116378615,"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",3
1644,0.1898936831274125,Acyl chain remodeling of CL,6
531,0.18988816586872934,RNA Polymerase III Transcription Initiation From Type 3 Promoter,56
1374,0.189773494411384,mitochondrial fatty acid beta-oxidation of saturated fatty acids,11
527,0.18966123089307824,Disassembly of the destruction complex and recruitment of AXIN to the membrane,57
1550,0.18959030648406883,Biosynthesis of maresins,8
370,0.18945085899770694,DNA Damage/Telomere Stress Induced Senescence,80
600,0.18939324524458578,XBP1(S) activates chaperone genes,48
1329,0.18930011351245515,Lysine catabolism,12
1168,0.1886206440086963,Phospholipase C-mediated cascade: FGFR1,16
135,0.18861146197842352,DNA Double-Strand Break Repair,166
380,0.18856776596211153,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,78
1364,0.18843578757971954,Vitamin D (calciferol) metabolism,11
1850,0.1882945148046348,TCF7L2 mutants don't bind CTBP,3
1177,0.18811281917125822,Pentose phosphate pathway,15
1432,0.1877628954816462,Bicarbonate transporters,10
846,0.1877074181663681,G-protein activation,28
1929,0.1876690218620554,Signalling to ERK5,3
903,0.1876343944776812,APC-Cdc20 mediated degradation of Nek2A,25
910,0.18758506884617926,MicroRNA (miRNA) biogenesis,25
2182,0.1874679640475132,"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",1
2183,0.1874679640475132,"TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",1
828,0.18736157401256562,Sulfur amino acid metabolism,30
1190,0.18710354783795582,Regulation of innate immune responses to cytosolic DNA,15
722,0.18686355281704367,Striated Muscle Contraction,36
1156,0.18685451776023923,Recycling of bile acids and salts,16
769,0.18684326175419044,Gluconeogenesis,33
1080,0.18615712318670058,Formation of ATP by chemiosmotic coupling,18
351,0.18612162082580813,RNA Polymerase II Pre-transcription Events,84
1838,0.1860061254246471,Signalling to STAT3,3
1110,0.18597263366993458,Translesion synthesis by POLK,17
88,0.18531591472071232,Signaling by Hedgehog,226
1042,0.18525048208693176,SHC-mediated cascade:FGFR4,20
1074,0.18517939790288432,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),19
1506,0.1851651228989549,VLDL clearance,9
389,0.18490096269837505,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,76
1804,0.18487015737384688,Synthesis of IPs in the nucleus,4
1163,0.18480798060058012,Spry regulation of FGF signaling,16
692,0.18467321039627507,Ovarian tumor domain proteases,38
1333,0.18463774224613239,Purine ribonucleoside monophosphate biosynthesis,12
1392,0.18452668190724106,Activation of RAC1 downstream of NMDARs,11
649,0.18452214833991093,"Gamma carboxylation, hypusine formation and arylsulfatase activation",42
1162,0.18442674058829747,Unwinding of DNA,16
48,0.18431022341684097,Chromatin organization,338
49,0.18431022341684097,Chromatin modifying enzymes,338
438,0.18407586918406466,Regulation of RAS by GAPs,68
1731,0.18376828150865396,Heme degradation,5
282,0.1837557859847539,Processing of DNA double-strand break ends,98
1519,0.18374943632765373,Transport of fatty acids,8
310,0.1835681513817814,ER-Phagosome pathway,93
2007,0.18356174081885937,Fructose biosynthesis,2
792,0.18350172084751964,Termination of translesion DNA synthesis,32
1755,0.18349602295369344,Tyrosine catabolism,5
385,0.18341862652593552,RNA Polymerase III Transcription,77
383,0.1832296845095829,DNA Double Strand Break Response,77
890,0.18322644200788216,Activation of SMO,26
1019,0.18301670279061297,NRIF signals cell death from the nucleus,20
372,0.18290555733136746,Meiotic synapsis,79
1701,0.18274456999263436,Signalling to p38 via RIT and RIN,5
456,0.18265051499553442,TP53 Regulates Transcription of DNA Repair Genes,65
1984,0.1825086905908364,Events associated with phagocytolytic activity of PMN cells,2
590,0.18231534745131397,HDMs demethylate histones,50
1770,0.1822310209768509,Catecholamine biosynthesis,4
796,0.18173684454156752,Cristae formation,31
1444,0.18168664290112993,Folding of actin by CCT/TriC,10
1790,0.18160892282511715,Lysosomal oligosaccharide catabolism,4
614,0.18151916164716705,Regulation of beta-cell development,46
41,0.18143476415660076,DNA Repair,393
679,0.18140818178092083,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,39
198,0.18126854576505672,Peroxisomal protein import,123
1874,0.18121587437783834,STAT6-mediated induction of chemokines,3
488,0.18102466552404972,Formation of RNA Pol II elongation complex ,61
486,0.18102466552404972,RNA Polymerase II Transcription Elongation,61
2165,0.18058984561669414,Essential pentosuria,1
82,0.18055302688323938,Neddylation,234
119,0.18034758180171584,Transcriptional regulation by RUNX2,181
425,0.1803148241133526,Nonhomologous End-Joining (NHEJ),69
201,0.1801997065293792,Activation of HOX genes during differentiation,123
199,0.1801997065293792,Activation of anterior HOX genes in hindbrain development during early embryogenesis,123
298,0.18011758350584525,Macroautophagy,95
1899,0.18004371004491396,Activation of BMF and translocation to mitochondria,3
706,0.18001540603975785,Metalloprotease DUBs,37
956,0.17994453026615662,RNA Polymerase III Transcription Termination,23
1050,0.17954237994722597,Phosphorylation of the APC/C,19
928,0.1793065066725933,Xenobiotics,24
168,0.1792694069249514,Pre-NOTCH Expression and Processing,139
1596,0.17919932545234188,Acyl chain remodeling of DAG and TAG,7
1583,0.17915298757571763,DNA Damage Reversal,8
2055,0.1791423039402707,MPS IIIA - Sanfilippo syndrome A,1
1002,0.17909037724643018,ER Quality Control Compartment (ERQC),21
138,0.17879473451135058,Late Phase of HIV Life Cycle,162
56,0.17874234360440625,Deubiquitination,306
352,0.17865607564323144,Transport of Mature Transcript to Cytoplasm,84
2088,0.17836390554006507,Defective PGM1 causes PGM1-CDG (CDG1t),1
384,0.17829387987851927,ABC transporter disorders,77
379,0.17810560739429712,The role of GTSE1 in G2/M progression after G2 checkpoint,78
390,0.17785273873582436,Transport of Mature mRNA derived from an Intron-Containing Transcript,75
501,0.17784407539752867,rRNA modification in the nucleus and cytosol,60
150,0.17778233115565653,Gene Silencing by RNA,150
507,0.177766670181666,E3 ubiquitin ligases ubiquitinate target proteins,59
460,0.1777165778827496,RNA Polymerase I Transcription Initiation,65
1723,0.17761362898258484,Propionyl-CoA catabolism,5
331,0.17754490978289642,Signaling by NOTCH4,89
726,0.17751982500496927,DNA strand elongation,36
602,0.17719088948870715,RNA Polymerase II Promoter Escape,47
611,0.17719088948870715,RNA Polymerase II Transcription Initiation And Promoter Clearance,47
607,0.17719088948870715,RNA Polymerase II Transcription Initiation,47
604,0.17719088948870715,RNA Polymerase II HIV Promoter Escape,47
603,0.17719088948870715,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,47
609,0.17719088948870715,HIV Transcription Initiation,47
1054,0.17710904998901106,Plasma lipoprotein assembly,19
2101,0.17685663685622563,"Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",1
1283,0.17609069564194646,FGFR2c ligand binding and activation,13
76,0.17608787376916085,Processing of Capped Intron-Containing Pre-mRNA,242
2145,0.17570927829863375,Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),1
1217,0.17562843338048492,Glutamate and glutamine metabolism,14
889,0.17557061035020013,Calnexin/calreticulin cycle,26
81,0.1754772858206588,Signaling by ROBO receptors,234
690,0.17539219400142114,Fanconi Anemia Pathway,39
1799,0.17519569025137782,HCN channels,4
2203,0.1751912386257145,Defective DOLK causes DOLK-CDG (CDG-1m),1
349,0.17513000478485777,Protein ubiquitination,84
1053,0.17512505545076382,Regulation of TP53 Activity through Methylation,19
1787,0.17510416283549005,Classical Kir channels,4
1087,0.17504404641969382,Purine catabolism,18
1655,0.17503034531999473,Molybdenum cofactor biosynthesis,6
1438,0.17484978604290707,Ketone body metabolism,10
1347,0.17443491925448526,TICAM1-dependent activation of IRF3/IRF7,12
1780,0.17379999121576983,Loss of MECP2 binding ability to 5mC-DNA,4
409,0.17379756570427984,RNA Polymerase III Transcription Initiation,72
128,0.1737948147048181,Hedgehog 'off' state,174
210,0.17365255825600287,Meiosis,119
404,0.17358519546798676,Activation of NF-kappaB in B cells,73
184,0.17331553047893378,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),132
170,0.1730728773407314,Homology Directed Repair,138
853,0.17272559459913697,Processing of Capped Intronless Pre-mRNA,28
1258,0.17225157056252208,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),14
236,0.17224091757689802,Amyloid fiber formation,109
842,0.17208763308597488,Peroxisomal lipid metabolism,29
825,0.17206491581734923,HSF1 activation,30
1029,0.17199429253830664,Lagging Strand Synthesis,20
283,0.17188765760184407,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,98
1720,0.17186087775356484,Trafficking of myristoylated proteins to the cilium,5
599,0.17185947154584602,The phototransduction cascade,48
1670,0.17134720334775863,Negative feedback regulation of MAPK pathway,6
1691,0.1710632453081535,Activation of NOXA and translocation to mitochondria,5
815,0.17104777036791222,Regulation of TP53 Activity through Acetylation,30
832,0.17084310470025799,mRNA Capping,29
1466,0.1702925793836131,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,9
107,0.17012622634237304,mRNA Splicing,188
20,0.16985681158496382,Metabolism of RNA,735
415,0.16973016013596237,PKMTs methylate histone lysines,71
1592,0.16968531827458463,SUMO is conjugated to E1 (UBA2:SAE1),7
401,0.16963678809600727,Nucleosome assembly,73
403,0.16963678809600727,Deposition of new CENPA-containing nucleosomes at the centromere,73
207,0.16958333006092224,Pre-NOTCH Transcription and Translation,120
120,0.16954549573011335,mRNA Splicing - Major Pathway,180
499,0.16954186852443648,SCF(Skp2)-mediated degradation of p27/p21,60
1469,0.16951651337971918,Neurofascin interactions,9
849,0.169505597827666,Energy dependent regulation of mTOR by LKB1-AMPK,28
1174,0.16944113422089194,Processing and activation of SUMO,15
1856,0.1692892982644216,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,3
974,0.1692143641381586,mTORC1-mediated signalling,22
1254,0.16914393905758804,Removal of the Flap Intermediate,14
1497,0.16910756426973983,Activated NTRK3 signals through PI3K,9
683,0.16889674947473118,mTOR signalling,39
622,0.16878118067236525,tRNA modification in the nucleus and cytosol,45
958,0.16870532827584653,activated TAK1 mediates p38 MAPK activation,23
1927,0.1679006395537788,Interconversion of polyamines,3
1144,0.16781454208221402,Processing of SMDT1,16
1591,0.1677964857971059,Sulfide oxidation to sulfate,7
90,0.1677730340047501,Ub-specific processing proteases,221
234,0.16746811761360603,Chromosome Maintenance,109
1286,0.16742154699902567,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",13
219,0.16731470572697615,Senescence-Associated Secretory Phenotype (SASP),114
80,0.16715069235498536,Epigenetic regulation of gene expression,234
70,0.16664754005868238,Protein localization,261
995,0.1665935373095675,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",21
159,0.16636466573360945,Reproduction,145
247,0.16610887626260287,Hedgehog 'on' state,105
871,0.16604550800773654,RNA Pol II CTD phosphorylation and interaction with CE,27
868,0.16604550800773654,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,27
243,0.16580731324505066,Transcriptional regulation by small RNAs,107
2004,0.16537071228569877,Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),2
961,0.16524796186449345,APC/C:Cdc20 mediated degradation of Cyclin B,23
1651,0.16521804940436338,Vasopressin-like receptors,6
1742,0.16500015348919295,Vitamin B1 (thiamin) metabolism,5
459,0.1648367924038627,Asymmetric localization of PCP proteins,65
1380,0.1647257418172158,Beta-oxidation of very long chain fatty acids,11
1231,0.1643003921790636,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",14
1535,0.16405286205504016,Defects in biotin (Btn) metabolism,8
302,0.16331309713880435,Degradation of beta-catenin by the destruction complex,95
525,0.16315217371617044,mRNA 3'-end processing,57
933,0.16301104633659033,Cytosolic tRNA aminoacylation,24
1175,0.16276775799051865,Processive synthesis on the lagging strand,15
969,0.1623604048601859,Citric acid cycle (TCA cycle),22
1295,0.16236013954794692,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",13
820,0.16228195309178653,Recognition of DNA damage by PCNA-containing replication complex,30
1800,0.16214267919907313,NR1D1 (REV-ERBA) represses gene expression,4
335,0.16207594870753264,Regulation of mRNA stability by proteins that bind AU-rich elements,88
505,0.16196024559545436,Translation initiation complex formation,59
713,0.16193368081475806,Mitochondrial Fatty Acid Beta-Oxidation,37
1462,0.1619246677161083,Neurotransmitter clearance,10
639,0.16124274295952878,Formation of Incision Complex in GG-NER,43
2081,0.16121637548786957,Defective MPI causes MPI-CDG (CDG-1b),1
1844,0.16119833143291365,Toxicity of botulinum toxin type C (BoNT/C),3
1763,0.16102849247807294,Abacavir metabolism,5
1330,0.16097300637211742,FGFR1c ligand binding and activation,12
1013,0.16075672183635634,Synaptic adhesion-like molecules,21
966,0.16073218016360594,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,22
1526,0.1607202653241515,Recycling of eIF2:GDP,8
1961,0.16066116513507647,Enzymatic degradation of Dopamine by monoamine oxidase,2
1485,0.1606202760669167,Sperm Motility And Taxes,9
642,0.16059691600733128,"Inactivation, recovery and regulation of the phototransduction cascade",43
1910,0.16046032192185403,TWIK related potassium channel (TREK),3
511,0.160447723179255,Ribosomal scanning and start codon recognition,59
494,0.16043520713651446,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",60
695,0.16028839812500287,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,38
187,0.16025492210549747,Synthesis of DNA,130
1160,0.16020682350553192,Assembly Of The HIV Virion,16
563,0.1601621393456588,Formation of TC-NER Pre-Incision Complex,53
1600,0.15979262952057288,Reversal of alkylation damage by DNA dioxygenases,7
1794,0.15972509832219084,ALKBH3 mediated reversal of alkylation damage,4
1153,0.1597164157467536,Translesion synthesis by REV1,16
341,0.15967543356543856,APC/C-mediated degradation of cell cycle proteins,86
343,0.15967543356543856,Regulation of mitotic cell cycle,86
315,0.15959584642183222,B-WICH complex positively regulates rRNA expression,91
169,0.15941430440123608,DNA Replication,139
1118,0.15932997071901478,Protein methylation,17
293,0.15911642288099695,Transcription of the HIV genome,96
704,0.1588944485077199,DNA Damage Recognition in GG-NER,38
810,0.1586501438111749,Negative regulation of FGFR4 signaling,31
2178,0.1583725184370996,"Biosynthesis of A2E, implicated in retinal degradation",1
450,0.1583103368699217,RNA Polymerase II Transcription Termination,66
193,0.15828765668551836,Oxidative Stress Induced Senescence,126
2109,0.1582647554409048,Defective HEXA causes GM2G1,1
230,0.15821492657243316,Nucleotide Excision Repair,110
1112,0.15818354326176842,Translesion synthesis by POLI,17
350,0.1581214695562725,Global Genome Nucleotide Excision Repair (GG-NER),84
1292,0.15788777240164611,ERKs are inactivated,13
1206,0.1578264445390693,Nucleobase biosynthesis,15
1630,0.15760413124702283,IkBA variant leads to EDA-ID,7
628,0.15759384385192776,TBC/RABGAPs,44
1640,0.15757866778146967,Telomere Extension By Telomerase,6
741,0.1574245067439279,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,35
1246,0.15732756951798682,Methylation,14
324,0.1572308627719191,Switching of origins to a post-replicative state,90
1263,0.1571723490961042,Membrane binding and targetting of GAG proteins,14
1219,0.1571723490961042,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",14
1040,0.15701558167914223,p75NTR signals via NF-kB,20
1401,0.15700450628244036,Gamma-carboxylation of protein precursors,11
906,0.15669631396107164,"Incretin synthesis, secretion, and inactivation",25
1146,0.15664109563085052,mRNA decay by 3' to 5' exoribonuclease,16
1111,0.1564855544908613,p75NTR recruits signalling complexes,17
2024,0.1560627765354108,Glycogen storage disease type XV (GYG1),2
2041,0.1560627765354108,Glycogen storage disease type 0 (muscle GYS1),2
801,0.15594321670850161,Glyoxylate metabolism and glycine degradation,31
819,0.15590021271726698,Extension of Telomeres,30
1745,0.15588669208146405,The fatty acid cycling model,5
1750,0.15588669208146405,The proton buffering model,5
1694,0.15588669208146405,Mitochondrial Uncoupling Proteins,5
2187,0.15577401812418976,Glycogen storage disease type Ia (G6PC),1
2129,0.1555418947946209,Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),1
939,0.15548059895121633,Telomere C-strand (Lagging Strand) Synthesis,24
1487,0.15532741627535307,Transport of nucleotide sugars,9
434,0.15487263906920964,G1/S DNA Damage Checkpoints,68
155,0.15484364763550362,Formation of the beta-catenin:TCF transactivating complex,146
462,0.15481880786170585,Dual incision in TC-NER,65
1830,0.15478587012024303,Utilization of Ketone Bodies,4
1471,0.1546666724982888,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,9
733,0.15462800330223359,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,35
455,0.15460492504266077,p53-Dependent G1/S DNA damage checkpoint,66
453,0.15460492504266077,p53-Dependent G1 DNA Damage Response,66
1921,0.15458172830984282,Enzymatic degradation of dopamine by COMT,3
1070,0.15457803197151584,Synthesis of glycosylphosphatidylinositol (GPI),19
946,0.154473100855386,Digestion,23
468,0.15422101958918974,Gap-filling DNA repair synthesis and ligation in TC-NER,64
395,0.15419182801991577,Condensation of Prophase Chromosomes,74
555,0.1539827550016042,RNA Polymerase III Transcription Initiation From Type 2 Promoter,54
2130,0.15372264185111298,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),1
145,0.15369638065816435,Influenza Infection,156
661,0.1536626784042373,Dual Incision in GG-NER,41
399,0.15346734588233535,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,73
72,0.15342510286510194,rRNA processing,253
376,0.15321600870383664,RMTs methylate histone arginines,79
1605,0.1531439497456463,Synthesis of wybutosine at G37 of tRNA(Phe),7
1452,0.15309640561661741,Chylomicron assembly,10
327,0.1530292171122405,Mitochondrial translation termination,89
381,0.15295099114348965,Transcription-Coupled Nucleotide Excision Repair (TC-NER),78
393,0.15291493028122904,APC/C:Cdc20 mediated degradation of mitotic proteins,75
1349,0.152818214681423,Hormone ligand-binding receptors,12
980,0.15266034410551876,Regulation of gene expression in beta cells,22
1914,0.152616193773822,Metabolism of vitamin K,3
303,0.15249640277096094,HDACs deacetylate histones,94
189,0.15211993171286395,Regulation of RUNX2 expression and activity,130
96,0.1519952428891198,HATs acetylate histones,205
1706,0.15192453293375416,Electric Transmission Across Gap Junctions,5
1716,0.15192453293375416,Transmission across Electrical Synapses ,5
1957,0.15182135130427857,Defective Mismatch Repair Associated With PMS2,2
1934,0.15182135130427857,Defective Mismatch Repair Associated With MLH1,2
1098,0.15173519337503674,Serotonin Neurotransmitter Release Cycle,18
416,0.15169988007111032,Orc1 removal from chromatin,71
1390,0.1516864034280126,Biotin transport and metabolism,11
118,0.15164915475586885,Mitochondrial translation,182
1538,0.1514579814960903,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",8
1781,0.15125093939038692,Hypusine synthesis from eIF5A-lysine,4
387,0.15115325855823505,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,76
131,0.15082910424099874,Negative epigenetic regulation of rRNA expression,170
241,0.1507562791930491,UCH proteinases,107
408,0.1505083402187227,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,72
185,0.15043880287083766,RNA Polymerase I Transcription,130
124,0.15041945050872518,Mitochondrial translation elongation,176
1383,0.1503306158798069,Androgen biosynthesis,11
577,0.15018836172255173,mRNA Splicing - Minor Pathway,52
1460,0.15013064618295127,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",10
1632,0.1500691349494964,Activated NTRK3 signals through PLCG1,6
1134,0.14999740201867137,Acetylcholine Neurotransmitter Release Cycle,17
429,0.14986444657305964,SIRT1 negatively regulates rRNA expression,69
2059,0.14978338505262684,MPS VII - Sly syndrome,1
2049,0.1496648623879508,Mitochondrial transcription termination,1
333,0.14966195642820915,Mitochondrial translation initiation,89
1436,0.14963206274666532,Organic anion transporters,10
653,0.1494538714863833,tRNA Aminoacylation,42
530,0.14938312262864398,RNA Polymerase III Transcription Initiation From Type 1 Promoter,56
179,0.14936502310623703,RUNX1 regulates transcription of genes involved in differentiation of HSCs,133
1989,0.14933375973071564,PAOs oxidise polyamines to amines,2
190,0.1492270536383703,RNA Polymerase I Promoter Clearance,128
1619,0.1489580468113312,PP2A-mediated dephosphorylation of key metabolic factors,7
1991,0.14895448996218635,"Activation, translocation and oligomerization of BAX",2
1414,0.1489055950241718,Removal of aminoterminal propeptides from gamma-carboxylated proteins,10
368,0.14889727656122234,Regulation of APC/C activators between G1/S and early anaphase,80
1705,0.1488954071208293,Sodium-coupled phosphate cotransporters,5
77,0.14888812185211858,rRNA processing in the nucleus and cytosol,241
572,0.14865712435900733,"Formation of the ternary complex, and subsequently, the 43S complex",52
1783,0.14844798058624403,Wax biosynthesis,4
1611,0.14823527372859718,GLI proteins bind promoters of Hh responsive genes to promote transcription,7
1388,0.1478559561853978,Receptor Mediated Mitophagy,11
157,0.14772479054721796,Influenza Life Cycle,145
423,0.1474676779611907,Regulation of PTEN stability and activity,69
923,0.14744911116208734,Retrograde neurotrophin signalling,24
1276,0.1473269306014308,Cytosolic iron-sulfur cluster assembly,13
1410,0.14727542288106477,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,11
959,0.1469894327906397,Mitochondrial calcium ion transport,23
2093,0.14691369515847835,Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD),1
601,0.14669007769189438,Formation of HIV elongation complex in the absence of HIV Tat,48
1496,0.14648089563949523,PI5P Regulates TP53 Acetylation,9
2020,0.14643691325326155,Biosynthesis of maresin conjugates in tissue regeneration (MCTR),2
1939,0.14643691325326155,Biosynthesis of DHA-derived sulfido conjugates,2
1411,0.14640568493899675,SLBP independent Processing of Histone Pre-mRNAs,10
133,0.14634513508143368,Positive epigenetic regulation of rRNA expression,167
1847,0.1462723657409589,SMAD4 MH2 Domain Mutants in Cancer,3
1843,0.1462723657409589,SMAD2/3 MH2 Domain Mutants in Cancer,3
1908,0.1462723657409589,Loss of Function of SMAD4 in Cancer,3
345,0.14614108390368596,DNA Replication Pre-Initiation,85
1101,0.14612435122225398,KSRP (KHSRP) binds and destabilizes mRNA,18
1657,0.14608443035557306,Alpha-oxidation of phytanate,6
1517,0.14607958798279272,WNT mediated activation of DVL,8
134,0.1460146254168934,NoRC negatively regulates rRNA expression,166
1951,0.1459726423509473,TWIK-related alkaline pH activated K+ channel (TALK),2
1280,0.14582543173964657,MASTL Facilitates Mitotic Progression,13
412,0.14540225244405783,CDK-mediated phosphorylation and removal of Cdc6,72
2011,0.1452721313333335,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),2
1647,0.14524775038098767,GDP-fucose biosynthesis,6
174,0.14394503572236717,Influenza Viral RNA Transcription and Replication,136
1515,0.14385285561387498,Regulation of gene expression in early pancreatic precursor cells,8
978,0.14378083002793327,Pink/Parkin Mediated Mitophagy,22
1551,0.14368845620621343,Synthesis of PG,8
772,0.14345702637676935,Formation of the HIV-1 Early Elongation Complex,33
770,0.14345702637676935,Formation of the Early Elongation Complex,33
318,0.14307916563034817,RNA Polymerase I Promoter Escape,91
427,0.14302368327856121,Hedgehog ligand biogenesis,69
1633,0.1429547917232087,Acrosome Reaction and Sperm:Oocyte Membrane Binding,6
2232,0.14259488242629706,Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),1
508,0.14248751594696357,Metabolism of polyamines,59
1606,0.14220497831205278,Defective HLCS causes multiple carboxylase deficiency,7
1636,0.14194125794272341,Methionine salvage pathway,6
1434,0.14170857031417938,Organic cation transport,10
487,0.1414152133636789,Defective CFTR causes cystic fibrosis,61
1836,0.14135260859874857,Histamine receptors,4
359,0.14128595061547722,Telomere Maintenance,82
337,0.1408547728910416,Meiotic recombination,87
1562,0.1406348222501592,Coenzyme A biosynthesis,8
1096,0.14049526024070635,RNA Polymerase III Chain Elongation,18
2155,0.14046473412318294,Defective GALE can cause Epimerase-deficiency galactosemia (EDG),1
1302,0.1400140639427274,Mitochondrial iron-sulfur cluster biogenesis,13
447,0.13991083995803685,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,67
1565,0.13986706919282968,Noncanonical activation of NOTCH3,8
116,0.13985246324915032,Major pathway of rRNA processing in the nucleolus and cytosol,183
1890,0.13985104632152554,Serotonin clearance from the synaptic cleft,3
1316,0.13977506426642916,Presynaptic depolarization and calcium channel opening,12
1489,0.1394940132590366,Displacement of DNA glycosylase by APEX1,9
1626,0.13903744179337965,Highly sodium permeable acetylcholine nicotinic receptors,7
436,0.13892499263908503,Assembly of the pre-replicative complex,68
2108,0.13886300857841213,Defective GSS causes Glutathione synthetase deficiency (GSS deficiency),1
31,0.13859789060188246,Translation,480
543,0.138456725204118,Degradation of AXIN,55
1660,0.13816186621924822,Phosphorylation of Emi1,6
510,0.13801284840850506,CDT1 association with the CDC6:ORC:origin complex,59
553,0.1378618077613491,Vif-mediated degradation of APOBEC3G,54
422,0.13757455886845077,HIV Transcription Elongation,69
432,0.13757455886845077,Tat-mediated elongation of the HIV-1 transcript,69
433,0.13757455886845077,Formation of HIV-1 elongation complex containing HIV-1 Tat,69
1979,0.13757320788746535,Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,2
840,0.13711941247780318,TRAF6 mediated IRF7 activation,29
122,0.13679570570866853,Regulation of expression of SLITs and ROBOs,178
492,0.13655885782846056,Degradation of GLI2 by the proteasome,60
1363,0.13647894646678738,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,11
1658,0.13645920180436494,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,6
402,0.13636158932541764,PRC2 methylates histones and DNA,73
480,0.1363370558258213,Dectin-1 mediated noncanonical NF-kB signaling,62
569,0.1361451880711477,Vpu mediated degradation of CD4,52
1297,0.13540067642877573,NF-kB is activated and signals survival,13
410,0.13531963036324526,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,72
491,0.1351734859103251,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,61
489,0.1351734859103251,Depyrimidination,61
490,0.1351734859103251,Cleavage of the damaged pyrimidine ,61
1140,0.13508312894990268,MAP3K8 (TPL2)-dependent MAPK1/3 activation,17
445,0.13501390053211468,APC/C:Cdc20 mediated degradation of Securin,67
2058,0.135008119989804,MPS I - Hurler syndrome,1
560,0.13463217048363943,Regulation of Apoptosis,53
1736,0.13424822564854974,Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,5
478,0.13424340234001128,Degradation of GLI1 by the proteasome,62
730,0.13402180176875553,Pausing and recovery of HIV elongation,36
715,0.13402180176875553,HIV elongation arrest and recovery,36
238,0.13400079855629707,Recognition and association of DNA glycosylase with site containing an affected purine,109
237,0.13400079855629707,Cleavage of the damaged purine,109
233,0.13400079855629707,Depurination,109
2029,0.13393156982594523,Interaction between PHLDA1 and AURKA,2
1490,0.13386204274133928,Highly calcium permeable nicotinic acetylcholine receptors,9
546,0.13381141599807392,Regulation of RUNX3 expression and activity,55
214,0.13367010992489325,"Base-Excision Repair, AP Site Formation",116
526,0.13362095247887484,Stabilization of p53,57
1067,0.13361396030286105,Golgi Cisternae Pericentriolar Stack Reorganization,19
209,0.1335961126739627,Selenoamino acid metabolism,119
904,0.13303935558940622,Gap-filling DNA repair synthesis and ligation in GG-NER,25
885,0.13300854226573158,Fertilization,26
565,0.13285464555675242,Packaging Of Telomere Ends,52
1953,0.13268836710211268,Inhibition of Host mRNA Processing and RNA Silencing,2
1634,0.13261195440259052,Activated NTRK2 signals through CDK5,6
1997,0.13233936729708934,GABA synthesis,2
838,0.1323333559092313,Mitophagy,29
1066,0.1322134774803201,Translesion Synthesis by POLH,19
1406,0.13218334378965332,Signaling by activated point mutants of FGFR1,11
473,0.13215507566718376,Autodegradation of Cdh1 by Cdh1:APC/C,63
1365,0.13185521822998422,SUMOylation of immune response proteins,11
1141,0.13184629682563212,Diseases associated with N-glycosylation of proteins,17
1159,0.13156401360479628,Metabolism of porphyrins,16
2194,0.13150217148979187,Defective ALG3 causes ALG3-CDG (CDG-1d),1
161,0.13144680893570027,Base Excision Repair,144
354,0.1313439845655416,Mitochondrial protein import,83
1815,0.1311993618342901,Activation of AKT2,4
1912,0.1311932113493104,Defective NEU1 causes sialidosis,3
222,0.1309883903666562,GTP hydrolysis and joining of the 60S ribosomal subunit,113
579,0.13091308600843052,Regulation of ornithine decarboxylase (ODC),51
1643,0.13079480048078423,Synthesis of Dolichyl-phosphate,6
386,0.13047915176595642,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,76
502,0.1304707175866029,NIK-->noncanonical NF-kB signaling,59
223,0.13017682349947096,L13a-mediated translational silencing of Ceruloplasmin expression,112
537,0.13017570065568917,AUF1 (hnRNP D0) binds and destabilizes mRNA,55
947,0.129954970652011,Abortive elongation of HIV-1 transcript in the absence of Tat,23
206,0.12984256112003886,Cap-dependent Translation Initiation,120
208,0.12984256112003886,Eukaryotic Translation Initiation,120
498,0.12943955968198947,GLI3 is processed to GLI3R by the proteasome,60
575,0.1291930844668265,Autodegradation of the E3 ubiquitin ligase COP1,52
1242,0.12900179459484584,Acetylcholine binding and downstream events,14
1224,0.12900179459484584,Postsynaptic nicotinic acetylcholine receptors,14
2099,0.1282288593391829,Defective GALT can cause Galactosemia,1
1503,0.12822690509505774,Synthesis of diphthamide-EEF2,9
1548,0.12806871402365327,POLB-Dependent Long Patch Base Excision Repair,8
1102,0.12796233938440416,Norepinephrine Neurotransmitter Release Cycle,18
750,0.12728210308173218,Pausing and recovery of Tat-mediated HIV elongation,34
752,0.12728210308173218,Tat-mediated HIV elongation arrest and recovery,34
457,0.12720750391548638,DNA methylation,65
1676,0.1267200370346768,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,6
1964,0.126594283474912,BDNF activates NTRK2 (TRKB) signaling,2
2019,0.126358511202228,Activation of Na-permeable kainate receptors,2
1188,0.12594789829187097,Phospholipase C-mediated cascade; FGFR4,15
1352,0.12579292482210283,Presynaptic nicotinic acetylcholine receptors,12
2193,0.12562810901966634,Defective ALG12 causes ALG12-CDG (CDG-1g),1
976,0.1251939195722157,Signaling by NODAL,22
1809,0.12499564703874427,HHAT G278V abrogates palmitoylation of Hh-Np,4
693,0.12446317939889733,Resolution of Abasic Sites (AP sites),38
1876,0.12429463873030076,IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),3
1877,0.12429463873030076,IKBKB deficiency causes SCID,3
504,0.12424606507911366,Hh mutants abrogate ligand secretion,59
588,0.12416599863640009,Regulation of activated PAK-2p34 by proteasome mediated degradation,50
554,0.12412989173082734,Ubiquitin-dependent degradation of Cyclin D,54
1000,0.12410534824422571,Mitochondrial tRNA aminoacylation,21
2065,0.12408474916948939,MPS IV - Morquio syndrome B,1
570,0.12398680291668766,p53-Independent DNA Damage Response,52
568,0.12398680291668766,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,52
576,0.12398680291668766,p53-Independent G1/S DNA damage checkpoint,52
2111,0.12382200390340532,Defective HK1 causes hexokinase deficiency (HK deficiency),1
2156,0.12379124431972854,Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7),1
1972,0.12348931827652335,Metabolism of serotonin,2
2115,0.12322241594983181,Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),1
1328,0.12320433651707101,Serotonin receptors,12
1454,0.12313410280260284,mRNA Editing,10
1764,0.12303506137205796,Tachykinin receptors bind tachykinins,5
1916,0.12279114484995723,Lactose synthesis,3
215,0.12276951431166197,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),116
216,0.12276951431166197,Nonsense-Mediated Decay (NMD),116
528,0.12243877963637333,Degradation of DVL,57
533,0.12239164783648074,Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,56
1766,0.12231824580760231,Dopamine clearance from the synaptic cleft,4
1739,0.12210189125086171,VLDL assembly,5
1500,0.1220152588447204,Opsins,9
1882,0.1216532827953123,Intracellular oxygen transport,3
2152,0.12134260531793563,Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),1
911,0.12109359891851039,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,25
472,0.12035328957731475,RNA Polymerase I Promoter Opening,63
1382,0.11951949388667935,Regulation of signaling by NODAL,11
1362,0.11941491399596355,Digestion of dietary carbohydrate,11
1898,0.11907124348490446,"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",3
548,0.11815837529322519,SCF-beta-TrCP mediated degradation of Emi1,55
1863,0.11803666715759553,The NLRP1 inflammasome,3
1319,0.11803437488803557,Ligand-receptor interactions,12
618,0.11758531801303809,Regulation of IFNA signaling,45
1621,0.11740684118251037,Phosphate bond hydrolysis by NUDT proteins,7
538,0.1165589848433325,Negative regulation of NOTCH4 signaling,55
265,0.11654605434969673,Formation of a pool of free 40S subunits,102
535,0.11611509438417779,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,55
2018,0.11602298427904938,"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",2
1227,0.11562561094051435,FGFR4 ligand binding and activation,14
1743,0.11504603473730604,Beta oxidation of hexanoyl-CoA to butanoyl-CoA,5
1902,0.11487060541166168,MECP2 regulates transcription of genes involved in GABA signaling,3
94,0.11195187273921815,SRP-dependent cotranslational protein targeting to membrane,207
1925,0.11189587661706925,Cysteine formation from homocysteine,3
1738,0.11180397322268434,Release of apoptotic factors from the mitochondria,5
1588,0.11147761513092554,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,7
1420,0.11126736837188797,Removal of the Flap Intermediate from the C-strand,10
2095,0.11069103027746315,Defective MAN1B1 causes MRT15,1
1730,0.11064296567163226,Beta oxidation of octanoyl-CoA to hexanoyl-CoA,5
297,0.10995568899095755,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),96
2100,0.10885729477271602,Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),1
1709,0.10801553738753131,FBXW7 Mutants and NOTCH1 in Cancer,5
1749,0.10801553738753131,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,5
1402,0.10783480092122462,Heme biosynthesis,11
1397,0.10783408243367519,Processive synthesis on the C-strand of the telomere,11
918,0.1076581092025836,Glucuronidation,25
290,0.10741482402081161,Eukaryotic Translation Termination,97
1268,0.10728527927304506,IRAK1 recruits IKK complex,14
1266,0.10728527927304506,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,14
295,0.10704566416436755,Eukaryotic Translation Elongation,96
1348,0.10685262791329157,Josephin domain DUBs,12
1707,0.10624290428613989,"Sodium-coupled sulphate, di- and tri-carboxylate transporters",5
2094,0.10584089940019026,Defective MAOA causes Brunner syndrome (BRUNS),1
320,0.10570154172412037,Viral mRNA Translation,90
1857,0.10559349287898297,Beta oxidation of palmitoyl-CoA to myristoyl-CoA,3
1937,0.10511773353791946,Insulin effects increased synthesis of Xylulose-5-Phosphate,2
1368,0.10499189672431987,Interaction With Cumulus Cells And The Zona Pellucida,11
1855,0.10467877905883628,NTRK3 as a dependence receptor,3
1560,0.10467258788713538,Formation of the Editosome,8
1525,0.10467258788713538,mRNA Editing: C to U Conversion,8
1201,0.10463454764489168,Organic cation/anion/zwitterion transport,15
316,0.10442279283202648,Peptide chain elongation,91
1009,0.10376018603885463,PCNA-Dependent Long Patch Base Excision Repair,21
1509,0.10332714939363828,NTRK2 activates RAC1,9
309,0.10329418003508878,Selenocysteine synthesis,94
1769,0.10314176827712387,MTF1 activates gene expression,4
1938,0.1026491238846956,Defective LARGE causes MDDGA6 and MDDGB6,2
2163,0.10152057748108029,"Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1",1
1688,0.10087317426447343,Synthesis of GDP-mannose,5
2168,0.10000052117869028,"Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)",1
2036,0.0994524446687395,SDK interactions,2
2110,0.09937234096977691,Defective HEXB causes GM2G2,1
2035,0.09708554086116102,Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),2
2190,0.09705589775711884,Synthesis and processing of ENV and VPU,1
2204,0.09629937047418416,Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling,1
1514,0.09564524267767574,Relaxin receptors,8
1641,0.09545754242069311,Biosynthesis of maresin-like SPMs,6
2173,0.09362117070132489,Essential fructosuria,1
2166,0.09231847941938873,Defective ABCC6 causes pseudoxanthoma elasticum (PXE),1
1405,0.0916320863375323,Activated NTRK2 signals through FYN,11
1529,0.09148169621138388,Ubiquinol biosynthesis,8
1818,0.08987374181881272,NTF3 activates NTRK3 signaling,4
2179,0.08942533598883337,Hereditary fructose intolerance,1
2226,0.08923053003083439,Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4),1
2023,0.08921274573579159,Synthesis of PS,2
1888,0.08854040309761585,Intestinal saccharidase deficiencies,3
1917,0.08700521846285099,Type II Na+/Pi cotransporters,3
2123,0.08493989622179025,Defective SLC2A10 causes arterial tortuosity syndrome (ATS),1
1861,0.08485778981291454,Beta oxidation of myristoyl-CoA to lauroyl-CoA,3
2214,0.08428983913007082,"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)",1
2027,0.08344999979181447,NTF3 activates NTRK2 (TRKB) signaling,2
1778,0.08223999176443586,Resolution of AP sites via the single-nucleotide replacement pathway,4
2006,0.08217351604791796,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,2
1983,0.08217351604791796,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,2
28,0.08171723969924652,G alpha (s) signalling events,545
2153,0.08047140698478594,Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ,1
1999,0.08021312402373698,Intestinal infectious diseases,2
2048,0.07993308164080634,Loss of MECP2 binding ability to 5hmC-DNA,1
1698,0.07948223044249095,Diseases of Base Excision Repair,5
1936,0.07833264428071066,Activation and oligomerization of BAK protein,2
2078,0.07794061359857686,Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC,1
2149,0.07717739745857247,Defective SLC5A2 causes renal glucosuria (GLYS1),1
1966,0.07517295848064005,"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",2
2222,0.0707085428729911,Defective Base Excision Repair Associated with NEIL1,1
1911,0.06862982494723742,"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",3
1909,0.06862982494723742,"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",3
2209,0.06824014948293108,Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency),1
1394,0.06807800323520218,CYP2E1 reactions,11
2128,0.06795895207423654,Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),1
1905,0.06588327034878198,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,3
1557,0.06474111137119584,Conjugation of salicylate with glycine,8
1712,0.06441057521167429,Dopamine receptors,5
2117,0.06279785236431377,Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),1
1981,0.06270899025148538,Acetylation,2
1477,0.06215676418883111,Amino Acid conjugation,9
1495,0.06215676418883111,Conjugation of carboxylic acids,9
1656,0.06209291679089276,Conjugation of benzoate with glycine,6
2216,0.06199308548417258,Defective Base Excision Repair Associated with NTHL1,1
2085,0.06199308548417258,Defective NTHL1 substrate processing,1
2084,0.06199308548417258,Defective NTHL1 substrate binding,1
2148,0.061367250630767645,Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),1
1820,0.06031976377146629,Synthesis of PIPs in the nucleus,4
1943,0.058063336728140284,TWIK-releated acid-sensitive K+ channel (TASK),2
1747,0.05799408725325683,Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,5
2120,0.057727998074616656,"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",1
2015,0.056214372787881814,Defective ABCC8 can cause hypoglycemias and hyperglycemias,2
2089,0.05587597176534399,Defective PMM2 causes PMM2-CDG (CDG-1a),1
2033,0.055082825765731445,Defective ABCG5 causes sitosterolemia,2
2034,0.055082825765731445,Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,2
688,0.05482035333948456,Class C/3 (Metabotropic glutamate/pheromone receptors),39
1940,0.05436162126665789,Defective ABCA1 causes Tangier disease,2
2037,0.05275210009520436,Glycogen storage disease type II (GAA),2
1919,0.05173471328411234,Inhibition of TSC complex formation by PKB,3
1556,0.051710539135675686,Orexin and neuropeptides FF and QRFP bind to their respective receptors,8
2043,0.05151853533274844,Vitamin E,1
1884,0.05058125371081693,Pyrimidine biosynthesis,3
2137,0.04651736881991244,"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",1
2185,0.04542445293648109,Phenylketonuria,1
2068,0.044707003186182225,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,1
2025,0.043480741982626456,Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,2
1998,0.04052324921069132,Proton-coupled neutral amino acid transporters,2
2116,0.04020286950712209,Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),1
2047,0.04009077998703592,MPS IV - Morquio syndrome A,1
2074,0.039835646615357774,Toxicity of tetanus toxin (TeNT),1
1700,0.03938552288675782,Serotonin and melatonin biosynthesis,5
1985,0.03751480851969556,Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),2
1860,0.037094716520509836,betaKlotho-mediated ligand binding,3
2083,0.036890629007520215,Defective MUTYH substrate processing,1
2010,0.036890629007520215,Defective Base Excision Repair Associated with MUTYH,2
2082,0.036890629007520215,Defective MUTYH substrate binding,1
2142,0.036758989736625225,Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),1
2189,0.036504173433591705,Synthesis of CL,1
1996,0.03636924240003195,Defective SLC3A1 causes cystinuria (CSNU),2
1950,0.03636924240003195,Defective SLC7A9 causes cystinuria (CSNU),2
2192,0.03484020967679762,FGFR4 mutant receptor activation,1
2151,0.03472490979251678,Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),1
2079,0.03471133588508589,Defective MOGS causes MOGS-CDG (CDG-2b),1
2162,0.031938006860263414,Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2,1
2022,0.030734886947757847,Conjugation of phenylacetate with glutamine,2
1722,0.03048650230631627,Organic anion transport,5
42,0.030232655666437038,Olfactory Signaling Pathway,393
2218,0.028393753464591335,Defective ALG9 causes ALG9-CDG (CDG-1l),1
2061,0.027191778812715544,Viral RNP Complexes in the Host Cell Nucleus,1
2138,0.027149268642561404,Defective SLC12A1 causes Bartter syndrome 1 (BS1),1
1968,0.02667622822332277,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),2
1960,0.02654819060002517,Rhesus blood group biosynthesis,2
1971,0.025527798300880804,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),2
2132,0.02499659599840471,Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),1
2014,0.024374708327291328,Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),2
2213,0.023415357670724606,Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4),1
2175,0.022530099811675988,Defective ALG2 causes ALG2-CDG (CDG-1i),1
2184,0.02154364279361386,Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),1
2112,0.021065489103695347,Defective SLC6A5 causes hyperekplexia 3 (HKPX3),1
2196,0.020955789609290204,Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2,1
2199,0.01945886171542655,Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B),1
2040,0.01885032796588272,Intestinal lipid absorption,2
2104,0.01834005191368153,Defective GIF causes intrinsic factor deficiency,1
2208,0.01743111950151629,Defective UGT1A1 causes hyperbilirubinemia,1
1931,0.016435618590438114,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),2
2227,0.016349611319345904,Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency),1
2198,0.014521971121738832,Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A),1
2207,0.012207796781639389,Defective UGT1A4 causes hyperbilirubinemia,1
2215,0.011952475174170007,Defective ALG6 causes ALG6-CDG (CDG-1c),1
1967,0.011213089756896456,Defective SLC6A19 causes Hartnup disorder (HND),2
2072,0.006947722252845083,TWIK-related spinal cord K+ channel (TRESK),1
2229,0.003992014080955239,Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5),1
2144,0.0038026532093474556,Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),1
2146,0.0035170939005570584,Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),1
1958,0.002197850865938059,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,2
2170,0.001551912772178539,Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD),1
2113,0.00019451265833271585,Defective RFT1 causes RFT1-CDG (CDG-1n),1
2191,8.980850843344021e-05,Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),1
2106,6.4068530076298215e-15,Regulation by TREX1,1
